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ABSTRACT OF DISSERTATION 
A RANDOMIZED CONTROLLED TRIAL OF ANESTHESIA GUIDED BY 
BIS VS. STANDARD CARE AND EFFECTS ON COGNITION 
Postoperative cognitive dysfunction (POCD) occurs frequently in individuals undergoing 
major surgery with general anesthesia.  POCD adversely affects morbidity and health-
related quality of life. Derived electroencephalographic (EEG) monitoring is utilized to 
guide the anesthesia provider in titration of volatile anesthetics. POCD has been 
associated volatile anesthetic neurotoxicity. EEG monitors are known to reduce a 
patient’s total cumulative dose exposure to volatile anesthetics. There is currently little 
evidence to support utilization of EEG monitors as a guide to reduce the incidence of 
POCD. 
The purpose of this dissertation was to develop and test a technique of general 
anesthesia, delivered by anesthesia providers and guided by the Bispectral Index™ (BIS) 
system EEG monitor. This technique was designed to reduce cumulative volatile 
anesthetic exposure and reduce cognitive decline. Prior to testing the intervention, 
preliminary work was conducted resulting in a review of evidence for current concepts in 
the mechanism of volatile anesthetics and their relationship with POCD. Based on 
information from these manuscripts, a randomized, controlled study was conducted to 
test the effects of BIS guided anesthetic technique on outcomes of middle aged patients 
undergoing impatient major surgery. 
Eighty-eight patients scheduled for major inpatient surgery were randomized to a 
BIS guided anesthetic, or to usual care control.  Although not in every cognitive domain, 
BIS guidance resulted in superior and not inferior performance in cognitive testing.  
The third manuscript documents predictors of cognitive decline. This was a 
secondary, planned data analysis of the previous prospective, randomized controlled trial. 
Consistent predictors of cognitive decline through the study phases were older age, lower 
income, and lower education. In addition to these, tobacco abuse is a significantly 
predictive characteristic.  
Further research should be focused on at risk cognitive domains, as well as, 
exploring other anesthetic regimens to avoid cognitive decline. 
KEYWORDS:  heart failure, anxiety, depression, hostility, trajectories, psychological 
symptoms 
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CHAPTER ONE 
Introduction 
Anesthesia is one of the greatest advancements in the health sciences. Anesthesia 
has not only made invasive procedures tolerable, but also has made countless surgical 
advancements possible. The last reported statistical summary by the Centers for Disease 
Control and Prevention indicated that there were over 48 million surgical procedures 
every year requiring general anesthesia, or the drug induced loss of response and 
perception of stimulation.1 The induced state of anesthesia is typically reversible and its 
consequences predictable and short-lived. Still, some individuals suffer cognitive deficits 
unexpectedly after surgery. Post-operative cognitive dysfunction, hereafter stated as 
POCD, is defined as negative changes in cognitive function that continue after 
appropriate drug half-lives have expired. 
Post-operative cognitive dysfunction was the focus of this dissertation because 
POCD adversely affects learning and memory for discharge and follow-up self-care 
instructions, short- and long- term recovery, and even mortality risk. In addition, I 
focused on POCD because the fastest growing segment of the population are the old and 
elderly, which is the group most likely to undergo surgery and also to begin to manifest 
mild cognitive impairment (MCI). These old (>60 years of age) and elderly (>75 years of 
age) individuals are the greatest consumers of health care.2 Maintaining function and 
independence are key components to maintaining quality of life, and the old and elderly 
are at greatest risk for POCD.3,4 
Many questions important to clinical practice about POCD are yet to be answered. 
Foremost among them is whether you are more at risk for POCD if you receive volatile 
2 
anesthetic agents during surgery. Other unanswered questions include, beyond age, what 
risk factors result in increased susceptibility for POCD. Are there techniques to reduce 
the impact of anesthesia on cognitive function? What are the most effective means to 
evaluate cognitive dysfunction perioperatively? I addressed some of these questions in 
this dissertation. The purposes of this dissertation were to (1) determine predictors of 
cognitive function among individuals scheduled for surgery using general anesthesia and 
volatile anesthetics; (2) determine predictors of cognitive dysfunction after surgery with 
general anesthesia and volatile anesthetics; and (3) determine if there are anesthetic 
delivery methods that can reduce the incidence of POCD. 
Post-operative Cognitive Dysfunction 
The symptomology of POCD is similar to that of delirium, and until the late 1990’s 
was not separated from the diagnosis of delirium. Improved understanding of POCD 
allowed for differentiation from delerium. Delerium is a vascillating inability to focus 
and maintain attention compared to POCD, which is a decline in cognitive function 
(typically in the memory and executive function domains) that lasts from days to months 
and in some cases, years. POCD, as a syndrome, is widely discussed in the literature, but 
is not listed in the Diagnostic and Statistical Manual of Mental Disorders (DSM-V).5 This 
is because a cognitive condition cannot have characteristics that could place it into 
another diagnosis (i.e., delirium, dementia, or amnestic disorder). 
Because POCD is not a defined disorder in the DSMMD and because 
neurocognitive testing is not routine and not available in all hospitals, POCD is largely 
under-appeciated by most clinicians. The objective finding of POCD requires baseline 
neurocognitive testing and follow-up testing at intervals after the effective half-lives of 
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anesthetics have passed. Usually, POCD is simply noted by the patient as “clouded 
thinking” or by family members as “something just not right”.  
 Symptoms of derangements similar to POCD have been reported for over 60 
years.6,7 Bryson and Wyand describe POCD as a subtle disorder of thought processes that 
may influence isolated domains of cognition such as verbal memory, visual memory, 
language comprehension, visuospatial abstraction, attention, or concentration, although 
the exact areas have not been definitively determined.8 These deficits in advanced 
cognitive function and memory continue after surgery and discharge from hospitalization 
and may last from days to years.9   
 In a seminal study, the incidence of POCD ranged from 10-50% depending on type 
of surgery.3 More recently, Monk and colleagues4 found that 30 to 41% of all adult 
patients experience POCD at discharge after surgery. This cognitive decline is associated 
with increased one year mortality, as well as morbidity and family/caregiver stress.4 The 
domains that appear to be most affected are attention and cognitive speed but also 
affected are executive function and memory.10 
Etiology of POCD 
 The etiology of POCD is unclear. A widely studied hypothesis for the mechanism 
underlying POCD alterations is neurotoxic injury. This association between anesthetics 
and the dementias has been suspected for over twenty years.11-13 Although there are many 
different anesthetics, the inhalation anesthetics (isoflurane, sevoflurane, and desflurane) 
are the basis of anesthesia used today. It is well described that inhalation anesthetics have 
effects demonstrated in histologic neuropathology similar to those seen in the senile 
dementias including Alzheimer’s disease (AD).  
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 Multiple neuropathogenic mechanisms of inhalation anesthetic have been described 
and are of increasing concern. The most prevalent of these are increased production and 
aggregation of amyloid beta (Aβ) peptides, increased caspase activation, and 
accumulation of hyperphosphorylated tau. Although there are many anesthetics and 
techniques available to obtain surgical anesthesia, some techniques involve use of high 
concentrations of volatile anesthetics.  These anesthetic techniques lead to higher 
cumulative doses of the anesthetic and have been demonstrated to produce higher 
histologic neuropathology from inflammatory changes 14-16 Lately, closer correlates have 
been drawn between anesthetics, POCD, MCI and AD.  This is because the cognitive 
domains of memory and executive function that are affected by POCD, MCI, and AD are 
similar.   
 Alzheimer’s disease, the most common form of dementia, is loss of mental ability 
affecting the cognitive domains of memory (short-term), verbal (expressive), 
visuospatial, and executive function. Mild cognitive impairment is a state of cognitive 
ability that falls below norms, but lacks the loss of function seen in the dementias. Mild 
cognitive dysfunction is considered a prodromal phase of dementia, and is suspected in 
individuals with memory deficits of the core cognitive domains (recall, language, 
visuospatial ability, and executive function).   
 Histological changes associated with AD and MCI are the basis for understanding 
the genesis of these conditions. The hallmarks for the histological neuropathology are 
Amyloid precursor protein (APP), Aβ, and hyperphosphorylation of tau. Amyloid 
precursor protein (APP) is an integral membrane protein believed to be involved in 
synapse formation.  Amyloid precursor protein is present in dendrites, cell bodies and 
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axons of neurons. Amyloid beta is a peptide enzymatically degraded from the larger APP 
that are released in neuronal damage. Amyloid beta deposits are neurotoxic, triggering 
retraction of axon terminals at target cells. Amyloid beta is also thought to trigger a 
chain-reaction of neuronal destruction in some individuals.17 Cumulatively, this is 
described as a senile plaque. Mild cognitive dysfunction is the result of similar 
neuropathologic changes. 
 Triggering of the apoptotic pathway and neuronal loss as a precursor to Aβ 
accumulation have been demonstrated in animal models of anesthetics. Isoflurane was 
demonstrated by to be an apoptotic neurodegeneration pathway in lower level mammals 
that were exposed to therapeutic doses of anesthesia in 2, 4, and 6 hour test groups.18 Xie 
and colleagues went on to associate isoflurane with caspase-3, a protein activated in the 
execution-phase of cell apoptosis.19 This finding was noted in a 2 hour exposure time and 
at a therapeutic isoflurane concentration of 1.4%.   
 In addition to Aβ, caspase-3 activation with neuronal apoptosis, and cortical 
hyperphosphorylated tangles of tau proteins are also noted in the neuropathology of AD. 
Research in POCD suggests similar neuropathologic changes. Loop and colleagues 
demonstrated that caspase-3 processing is provoked in a concentration/dose-dependent 
manner by sevoflurane and isoflurane, resulting in apoptosis.20 Further, sevoflurane 
induces caspase activation and apoptosis with subsequent increases of Aβ in human 
neuroglioma cells.21 Zhang and colleagues studied the volatile anesthetic desflurane.22 He 
found that desflurane alone did not induce caspase or Aβ but may when combined with 
hypoxia (18% FiO2). Further, exposure to and subsequent inflammatory changes from 
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volatile anesthetics are postulated to progress AD neuropathogenesis through these 
pathways.15,23  
 A common criticism of much of the research in POCD is the poor translation of 
bench science to clinical science with patients. This is a common obstacle with dementias 
studies, due to the obvious complications trying to translate the results of in-vitro studies 
to humans. Despite this difficulty, closer correlations are being noted between the 
dementias and POCD. Liu and colleagues concluded that individuals with amnestic MCI 
transitioned to progressive MCI in larger numbers in a group exposed to the inhalation 
anesthetic sevoflurane than those who had no exposure.24 In this study 55 individuals 
with MCI were exposed to an anesthetic with sevoflurane inhalation anesthetic. Of these, 
30 individuals were noted to have progressive/amnestic MCI at 2 years (P<0.01) and 13 
were diagnosed with AD. 
 Although, there is weighty evidence suggesting the risks of volatile anesthetics, this 
evidence does not warrant the exclusion of the anesthetics. In 2009 a POCD workshop 
was conducted with experts from anesthesia, neuroscience, and pharmacology. This 
group recognized the evidence linking inhalation anesthetics to the dementias is 
considerable on multiple levels of investigation, but that anesthetics provided an 
immediate benefit to society that outweigh these risks.36 
 In summary, although the etiology of POCD is unclear, the evidence supporting 
relationship of volatile anesthetics and neuronal inflammatory response is strong. This 
inflammatory response is particularly similar to that in MCI and AD. It is hypothesized 
that reducing the cumulative volatile anesthetic dose will reduce cognitive dysfunction. 
 
7 
Improving POCD Outcomes 
Classically, volatile anesthetic depth was titrated to Guedel’s classification, the 
presence or absence of various reflexes observed as anesthesia concentrations increased. 
Newer drugs, such as the neuromuscular-blocking drugs used today have obscured 
reflexes and thus the use of this classification system has declined. 
Electroencephalographic (EEG) activity monitors utilize time-domain, frequency-
domain, and dual spectral analysis of raw EEG signals to objectively measure level of 
consciousness.  The application of the Fourier transformation to EEG waveforms and 
subsequently, the correlation with depth of anesthesia ushered in development and use of 
bedside monitors to guide anesthesia dosing and optimize the depth of anesthesia used so 
that it is not too little or too much.  
Entropy-guided monitors measure EEG and, through proprietary algorithms, 
convert the degree of irregularity seen with the awake EEG and the more regular patterns 
seen with increasing depth of anesthesia to a value that can be used by the clinician to 
judge depth of anesthesia.  Although there are multiple proprietary platforms that are 
used to perform entropy-guided anesthesia, the one used in my study was the Bispectral 
Index™ system or (BIS). This platform is used by the majority of the market. 
There are multiple benefits to the use of BIS-guided anesthesia. Gan and colleagues 
established that a secondary benefit of this guided technique was a 13.4% reduction in 
anesthetic drug consumption.25 There are many other well-known benefits of entropy-
guided titration of anesthesia, such as shortened anesthesia emergence time and faster 
recovery.26 Investigators have further demonstrated that avoidance of deep anesthesia is 
associated with improved survival, reduced morbidity27 and improved 2-year mortality.28 
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Sessler and colleagues described the concept of “triple low” threat, consisting of 
hypotension, cumulative deep hypnotic time, and presence of co-morbidities, which leads 
to increased odds of one-year mortality.29  Cumulative deep hypnotic time (per hour) 
increased one-year mortality by 1.244% (P<0.0121). 
 In an important study in the field conducted in China, the Cognitive Dysfunction 
after Anesthesia (CODA) trial investigators demonstrated increased cognitive 
dysfunction after deep anesthesia.30  The investigators utilized BIS-guided anesthesia and 
titrated depth of anesthesia to a score of 40-60 (considered good general anesthesia with a 
low probability of explicit recall) in 462 individuals and another 459 were randomized to 
a blinded control group in which anesthesia was delivered without BIS-guidance.  The 
outcome of the study was cognitive function measured by a basic cognitive failure 
questionnaire including the verbal fluency test, Chinese auditory verbal learning test, and 
color trail making test.  The CODA trial investigators concluded that controlling 
anesthetic depth to a BIS guided range of 40-60 resulted in 83 patients for every 1000 
being protected from delirium during hospitalization and 23 avoiding POCD at 3 months 
after surgery31.  
 In another important study, investigators used the BIS to titrate depth of anesthesia.  
In this trial, Radtke and colleagues randomized 1277 individuals into two groups, one 
that received BIS titrated anesthesia (n=593) and one blinded to BIS values (n=600).32  
They found that there was a significant increase in delirium (p=0.015) in the patients 
cared for in the blinded group, but no significant differences in POCD were seen 
(p=0.062) between the two groups.  An interesting limitation of the study was the fact 
that the providers in the two groups did not produce differing anesthetic depths, likely 
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because the protocol allowed for unblinding of the provider who was allowed to use data 
from the BIS as deemed appropriated. 
 In summary, entropy guidance monitors have improved the anesthesia provider’s 
understanding of depth of anesthesia in real time. Over the past decade the availability 
and acceptance of these devises has become widespread. Previous studies have 
demonstrated the ability of entropy guidance monitors to positively change the 
neurocognitive outcomes for patients. These studies can be improved upon by elimination 
of confounding groups and more rigorous cognitive testing.   
Measurement of POCD Outcomes 
  There is no gold standard instrument for the study of POCD. A literature review 
of POCD studies by Newman and colleagues reported that at least 70 different measures 
were used alone and in combinations.33 There was little similarity in the domains of 
cognitive function studied (and in most cases, the investigators failed to report which 
domains they studied), in most cases arbitrary definitions of POCD were used and the 
definitions were poorly described making replication difficult. All of these problems 
create a barrier for POCD researchers in that the findings are difficult to compare 
amongst the studies and it is difficult to determine which instruments to use.  To date 
there is not a neurocognitive battery developed specifically for the study of POCD, nor a 
definitive study to indicate the optimum neurocognitive battery.  
 The Uniform Data Set (UDS) from the Alzheimer’s disease Centers program of the 
National Institute on Aging is currently utilized by 32 centers in the United States.34  The 
battery is administered by trained neuropsychologist in a clinical office setting. This 
battery is exhaustive, diagnostic, and used as part of a 918 variable data collection of 
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research participants, making its use in surgery patients quite difficult and not practical.  
Lewis noted that, in regard to studies of POCD, increasing the number of tests in a 
battery increases the sensitivity, but resulted in increasing false positive classifications 
and error.35 The landmark study of POCD is the International Study of Postoperative 
Cognitive Dysfunction study. This study utilized seven different test focusing different 
cognitive domains to complete the battery. These test and their domains included the 
visual verbal learning test (executive function), concept shifting test (executive function), 
Stroop color word interference test (executive function), paper and pencil memory 
scanning test (visual memory), letter-digit coding test (processing speed), and four boxes 
test (reaction time). 
   Although, other investigators have utilized the Cambridge Neuropsychological 
Test Automated Battery (CANTAB®) system to measure cognitive function, this 
dissertation includes the Cambridge Neuropsychological Test Automated Battery-Mild 
Cognitive Impairment (CANTAB-MCI®) battery for the first time in the anesthetic 
population and for the first time, we identified the specific domains of cognitive function 
being measured.  The CANTAB® is very sensitive for detecting mild cognitive 
impairment, the pre-dementia state most similar to postoperative cognitive dysfunction.  
Wide use of such a neurocognitive screening tool in clinical practice may alert providers 
in the future to individuals who need an augmented anesthetic, or will need progressive 
care postoperatively.  This could lead to reduced morbidity, mortality, as well as, patient 
and caregiver stress. 
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Overview of the Dissertation 
An obstacle in understanding POCD is that the exact mechanism whereby volatile 
anesthetics produce their effects is not currently known. Chapter Two of this dissertation 
is a review of the state of the science on the mechanism of inhalational anesthetics and 
how POCD might occur in that context. This chapter presents an integrative review of the 
literature that presents mechanisms that are plausible and their associations with 
neuropathogenic effects. 
 Chapter Three of this dissertation is a report of a randomized controlled trial of an 
anesthesia technique guided by the BIS monitor compared with standard care. In a 
sample of 86 individuals, 45 surgical patients randomized to the intervention of a 
balanced anesthetic technique with BIS guidance, and 43 to standard treatment. 
Individuals cognitive performance was evaluated with the Cambridge 
Neuropsychological Test Automated Battery-Mild Cognitive Impairment (CANTAB-
MCI®) at three intervals (preoperatively, 3-5 days post-operatively, and 3-5 months post-
operatively). An additional 37 age- and sex-matched individuals not undergoing surgery 
nor anesthesia were evaluated at the same intervals to represent a normative population. 
The purpose of the study was to determine if an anesthetic technique with cumulative 
deep hypnotic time result in a greater degree of POCD.  A two-way mixed repeated 
measures ANOVA was utilized to address this specific aim. 
Chapter Four of this dissertation is a review of the predictors of cognitive 
dysfunction as defined from the CANTAB-MCI battery. These were determined by 
statistical analysis of the randomized controlled trial described in Chapter 3. Predictors of 
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cognitive dysfunction are described for baseline, at early postoperative testing time, and 
late testing time. Parameter estimates were obtained and described in this chapter. 
 Chapter Five is an integrated summary and conclusions from the findings of the 
manuscript. Recommendations for contemporary clinical practice, as well as, future 
research are discussed in this chapter. The findings of the study are targeted as practical 
interventions that nurse anesthetists may use in any practice in the United States. 
Implications of this research are limiting the effect of anesthetics, in particular volatile 
anesthetics, on susceptible surgical populations.  
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CHAPTER TWO 
Anesthesia Mechanisms and the Aging Brain 
Introduction 
The use of anesthetics in the care of individuals undergoing surgery is one of the 
greatest accomplishments in the health sciences. Since Joseph Priestley’s work with 
nitrous oxide in 1772 and William Morton’s 1846 demonstration of ether anesthesia, 
anesthesia has become an increasingly important component of health care. The last 
reported statistical summary by the Centers for Disease Control and Prevention1 indicated 
that there were over 48 million surgical procedures requiring anesthesia performed in 
2009. 
Though widely used and accepted as safe, neither the molecular pharmacological 
site of action, nor the mechanisms of volatile anesthetic action are currently fully 
understood2. There have been no receptors directly identified that account for the activity 
of inhalational anesthetic activity. Nonetheless, the practice of anesthesia has evolved and 
allowed many of the great surgical advancements of modern medicine. 
Improvements in safety of anesthesia over the past five decades are largely 
attributed to improved patient monitoring and to optimal training of anesthesia providers. 
In the 1950’s anesthesia-related mortality rates were reported as 1 per 1560.3 More recent 
studies suggest that anesthesia-related mortality is 1.1 per million per year.4 The practice, 
however, seeks to realize a completely benign anesthetic experience. 
Growing interest in defining the risk associated with anesthesia is essential in 
quality improvement within the practice. Increasing age is an important risk factor for 
post-operative morbidity and mortality. By 2030, 20% of Americans will be older than 65 
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and 21% of those over 60 will receive anesthesia with surgery (compared with 12% of 
those 45-60) A better understanding of anesthesia risks in the elderly can improve 
outcomes. 
Post-operative cognitive dysfunction (POCD) is one such risk. There is controversy 
about the existence of an association between anesthesia and POCD5, yet there is a sound 
theoretical and physiologic basis for such an association particularly among older 
individuals. Of note, there are similarities in protein abnormalities seen in Alzheimer’s 
disease (AD), mild cognitive impairment (MCI) and POCD, which suggest a foundation 
for understanding the potential for POCD in older patients.6 The purpose of this paper is 
to integrate current concepts of the mechanisms of action of inhalational anesthetics, the 
pathology of AD and MCI, and the effects of anesthesia on the aging brain. The major 
concept underlying the relationship among these is protein inhibition. Protein inhibition 
results in anesthesia. Protein inhibition is associated with multiple deleterious processes, 
many of which are seen in AD, MCI and POCD and will be discussed below. 
Linking Protein Mechanisms to Postoperative Cognitive Dysfunction and Mild 
Cognitive Impairment 
Alzheimer’s disease and the prodromal state, MCI are two of the many types of 
dementia. Abnormalities in neuronal proteins have been studied in AD and other 
dementias for over three decades.7 Amyloid proteins are components of cell membrane. 
Normally, these proteins are dissolved in body fluids and utilized in new cell creation. 
Occasionally, these proteins become misfolded leading to clumping or aggregates. The 
misfolding or transformation of the peptides into aggregate proteins are toxic to other 
local, healthy cells The aggregation of amyloid proteins as a result of misfolding is a 
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leading theoretical mechanism in the AD pathway. Injury to neuronal cells can create a 
destructive cascade of injury to healthy cells that is ultimately manifested by dementia. 
 Mild cognitive impairment is described as a transitional zone or prodromal state to 
frank dementia. Typically, the dementias effect multiple cognitive domains, whereas, 
MCI effects a single cognitive domain.  MCI is a condition in which an individual 
displays memory problems disproportionate to their age.8 This prodromal state bridges 
normal cognitive function and the more severe dementias including clinical AD.9 The 
typical time period for MCI transition to a more severe dementia is 18 months.10 Volatile 
anesthetics have been associated with similar deficits in cognitive domains which have 
led researchers to study if there is an association or causal relationship. 
 Postoperative cognitive dysfunction is a subtle disorder of thought process that 
influences isolated domains of cognition such as verbal memory, visual memory, 
language comprehension, visuospatial abstraction, attention, or concentration11 after 
exposure to an anesthetic and that remains after drug half-lives have past. The cognitive 
domains affected in POCD are very similar to those affected in MCI. Symptoms of poor 
cognition after surgery have been reported for over 50 years,12 long before POCD was 
recognized and named. Postoperative cognitive dysfunction occurs in 27% and 10% of 
individuals over 60 years old, at 1 week and 3 months after non-cardiac surgery 
respectively,13 and has become a focus of anesthesia research among older and at-risk 
populations. Although there is no data to suggest that surgery aggravates existing AD, 
inflammation is a critical common pathology of both volatile anesthetic induced POCD 
and what is understood from the AD pathway. 
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Protein Abnormalities and Anesthesia 
The neuronal abnormalities and protein derangements seen in AD are similar to 
those seen with use of inhalation anesthetics. Amyloid beta protein (Aβ) aggregates or 
plaques are a hallmark of AD pathology. Aβ are a specific type of protein fragments left 
from neuronal destruction and are thought to be highly neurotoxic to healthy cells.  The 
next few paragraphs will highlight significant findings related to POCD pathology. 
Anesthetics can induce neurotoxicity via apoptotic neurodegeneration.  Apoptotic 
neurodegeneration is also known as programmed cell death. This is a process where a 
trigger induces the cell to dramatically alter the nucleus or other component leading to the 
cell death. Nikizad, Yon, Carter, and Jevtovic-Todorovic14 induced thalamic and cerebral 
cortex apoptosis, with clinically appropriate concentrations of volatile anesthetic in rat 
pups.  The resulting buildup of cellular components creates an imbalance of protein 
clearance leading to Aβ and oligomerization. 
 After neuronal destruction, cellular components are left behind and are further 
broken down and cleared in healthy individuals. As mentioned before, in AD a toxic 
aggregation of Aβ has been noted to appear in susceptible individuals without a clear 
cause. Oligomerization is the bonding of small peptides that will then form larger 
aggregates. Eckenhoff et al.15 demonstrated that volatile anesthetics effect 
oligomerization or the collection of Aβ, with in vitro rat models. These neurotoxic bodies 
are thought to cause further cell destruction and overwhelm the body’s ability to clear 
Aβ. Eckenhoff et al.15 enhanced Aβ oligomerization rates and subsequent neuro-
cytotoxicity with exposure to the common volatile anesthetics isoflurane and halothane.  
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Caspases, protease enzymes, are the principle executors of apoptotic pathways. Lu 
et al.16 showed increased caspase activation in rat pups after a sevoflurane anesthetic. Lu 
et al.16 observed increased apoptosis, altered precursor protein processing, and altered β-
amyloid protein levels. Xie et al.17 demonstrated dose-dependent activation of caspase-3 
and apoptosis in human neuroglioma cells with isoflurane. Six hour exposures to 
isoflurane at 1% showed no change in caspase-3 activation, although at 2% there was 
substantial activation and apoptosis. 
The state of the science in POCD research implicates important pathological 
outcomes from therapeutic concentrations of volatile anesthetics. Examination of 
mechanisms thought to explain the action of volatile anesthetics reveals how these 
anesthetics might produce POCD. 
The Classic Theory of Anesthetic Mechanisms 
Classical theories of anesthetic action have evolved over the last century. The 
Meyer-Overton Theory is the oldest concept of inhalational anesthetic action. This theory 
suggests that lipophilic molecules of anesthetics penetrate axons and inhibit neural 
transmission.18 This theory is supported by the concept of partition coefficient, the ratio 
of the unionized/ionized compound in a solution, which leads to a correlation between 
anesthesia concentration and potency.19 As newer medications have been evaluated with 
the Meyer-Overton Theory, inconsistencies in anesthetic reactions when considered 
under the tenets of the theory have limited acceptance of the theory today. In particular 
newer halogenated anesthetics (not commonly used in the United States) violate the 
proposition of the theory in that immobility or amnesia is not achieved at the predicted 
coefficient. Nonetheless, the Meyer-Overton Theory is still relevant today given that it is 
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the theory still used to consider issues of anesthetic potency of volatile anesthetics used 
currently. This is relevant to POCD because, a careful titration of the volatile anesthetic 
can reduce the dose needed, which reduces neuronal saturation resulting in lower risk for 
POCD. 
Protein Theory of Anesthetic Mechanisms 
Protein theories of anesthesia have been described for many years, and with the use 
of new investigative instruments, are a major focus of the current study of anesthesia 
mechanisms. During the induction phase of an anesthetic, tissues are saturated with 
micromolar anesthetic compounds. Due to the lipophilic nature of volatile anesthetics, 
there are many hydrophobic protein binding sites available for adherence of anesthetics 
beyond the neuronal bilayer. Bilayer, or neuronal cell wall proteins control nerve action 
potentials. Many of these proteins have hydrophobic pockets with water soluble amino 
acids cores. These hydrophobic pockets, which are typically binding sites for endogenous 
fatty acids, could be a site of competitive antagonism for micromolar anesthetic 
compounds. 
There are also α-helices in cell membrane proteins that may interact with 
anesthetics and inhibit protein function. Therefore, there are multiple sites where 
anesthetic interaction with neuronal proteins could produce wide-spread changes in lipid 
cell wall relationships, implicating anesthetic action in more sites than just the neuronal 
bi-layer. The following are just a few of the more convincing areas of volatile anesthetic 
binding and influence. 
A range of technologies, from crude to advanced, have been used to predict and 
visualize volatile anesthetic interaction with proteins. The principle demonstration of 
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anesthetic binding with proteins was found using firefly luciferase (the bioluminescent 
substance from the insect) by Franks and Lieb20 30 years ago. More recently, Streiff et 
al.21 expanded the firefly study by demonstrating that volatile anesthetics bind to the 
following other proteins: albumin, apoferritin, and the calcium-calmodulin complex. Of 
note, the calcium-calmodulin complex is a component of the signaling cascade of G-
proteins, integral to autonomic responses throughout the body. Blunting of the autonomic 
nervous system is a critical component of an anesthetic that can adversely affect 
cognitive function. 
 Infrared spectroscopy was utilized by Zou, Liu, and Blasie22 in 2009 to isolate a 
binding site for the volatile anesthetic, halothane, in a model of apo-hemoglobin protein. 
The model demonstrated that halothane has a weak interaction with the backbone peptide 
core but exerts an impact on the electrostatic environment of the protein. This is another 
demonstration of binding of volatile anesthetics within membrane protein, but further 
illustrates the mechanism of action of halothane by demonstrating that the protein charge 
is changed. 
Central Cholinergic Nervous System Proteins 
 There are several protein type ligand-gated ion channels associated with anesthetic 
mechanisms. The nicotinic acetylcholine receptors (nAChR) are a broad class of integral 
excitatory ligand-gated ion channel proteins. Nicotinic receptors are found in various 
physiologic systems, including the central nervous system.  These receptors are 
responsible for modulation of catecholamine, as well as serotonin, acetylcholine, GABA, 
and glutamate neurotransmitters. The nicotinic receptor pathophysiological function  
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implicated in anesthetic mechanism, as well as, the links to neuronal injury are listed 
below. 
 GABA, is a subclass of nicotinic wall protein receptor. It is known as the major 
inhibitory neuroreceptor. GABA receptors respond to neurotransmitters and diminish cell 
action potentials. Normally GABA activation is a gradual process in which negative 
membrane potential is maintained to prevent over-excitation. This process involves influx 
of chloride ions that hyperpolarize cell membranes thus inhibiting function. Induction of 
GABA the effect, is a widely accepted anesthesia mechanism. 
 There are multiple subclasses of GABA receptor (Figure 1), but the ligand-gated 
chloride (Cl) ion channel, GABAA is closely associated with volatile anesthetics.  The 
GABA receptor has a typical pentameric structure with a central pore. GABAA receptors 
contain volatile anesthetic/solvent-accessible space or intrahelical pockets as binding 
locations within these pores.  Volatile anesthetics are believed to modulate the GABAA 
receptor by acting directly or indirectly through a second messenger system.  Ernst, 
Bruckner, Boresch, and Sieghart24 described these intrahelical pockets as binding pockets 
that can exist in numerous drug-induced conformational states. Volatile anesthetics 
enhance γ-Aminobutyric acid (GABA) and glutamate inhibition of the central nervous 
system, establishing a hyperpolarized neuron23 that produces sedative effects.  
 Another technology used to improve understanding of the mechanism of anesthesia 
at the molecular-receptor level is photolabeling. Li et al.25 utilized photolabeling of a 
general anesthetic analog of etomidate ([3H] azietomidate), an intravenous anesthesia 
induction agent, at GABAA subunits. Photolabeling supported the early theory of GABA 
action by demonstrating the affinity of an anesthetic compound’s for specific amino acids 
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in a GABA component protein.  The photolabeling technique allows for observation of 
the specific anesthetic binding sites on the GABA methionines amino acids. The binding 
sites demonstrated were, αM1 transmembrane helix at α1Met-236 and βM3 
transmembrane helix at βMet-286 locations. 
 Providers rarely use etomidate, and halothane is no longer marketed in the US.  The 
more relevant anesthetics, sevoflurane and desflurane, also have GABA binding sites.  
Specifically, these two volatile anesthetics share the position of the GABA receptor 
Ser270 of the α1 and α2 subunits, but not the transmembrane 2 of the β2 subunit.26  In 
addition to binding at the GABA receptor and influencing neuronal membrane potential, 
inhibition of exocytosis of neurotransmitter production occurs.27  Suppression of 
neurotransmitter release is another mechanism of volatile anesthetic action at the GABAA 
subunits.  Amyloid β is thought to weaken GABAA receptors and produces similar 
synaptic inhibition in the AD pathway.28 Downregulation and weakened synaptic 
inhibition are plausible pathways in the mechanism of anesthesia and POCD. 
 5-HT3, or serotonin receptors, are another type of ligand-gated ion channel that 
belong to the same family as nAChR. These receptors are found in the peripheral and 
central nervous systems. Binding of serotonin opens the channel allowing flux of sodium, 
potassium, and calcium ions, typically producing excitatory effects. Interestingly, the 
electrostatic mechanism of anesthetic binding to receptor sites determines if there is an 
excitatory or inhibitory response, demonstrating a mechanism of anesthetic manipulation 
of a receptor18. Acrolein, a lipid peroxidation product that is  elevated in the AD brain 
and is toxic to neurons.  The volatile anesthetic sevoflurane has been shown to sequester 
22 
 
a substance acrolein. Thin sequestration may lead to further production of toxic species 
that led to neuronal vulnerability40. 
Additional Protein Types 
 Another type of protein channel is the N-methyl D-asparate (NMDA) receptor. 
NMDA receptors are ligand-gated, voltage-dependent integral proteins. In contrast to 
GABA receptors, NMDA receptors produce excitatory actions and potentate 
depolarization.  Dickinson et al.19 utilized molecular modeling to demonstrate that the 
volatile anesthetic, isoflurane, competitively inhibits glycine at the NMDA glycine 
receptor.  Manipulation of NMDA through drugs like memantine, have long been utilized 
in an attempt to slow the progression of AD. The association between NMDA and 
volatile anesthetics and POCD is still unclear here. 
 Another, lesser known, possible mechanism of anesthetic action is binding to the 
potassium channel subfamily of K member 2 proteins (2PK). 2PK channels, including the 
TREK1 and TASK subfamily of channels, are dual-pores that are present in every part of 
the central nervous system. These channels remain open to “leak” potassium passively, in 
order to maintain membrane potentials. These channels can be intrinsically dilated by 
arachidonic acid, lysophospholipids, and polyunsaturated fatty acids. Greater potassium 
leak stabilizes cells at hyperpolarized voltages, inhibiting neuronal firing. 
 Patel et al.20 studied the anesthetic influence of the volatile anesthetics halothane 
and isoflurane, as well as, other volatile anesthetics on the neuronal tissue of the Lymnea 
stagnalis mollusk. The study reflected increased channel permeability by halothane and 
isoflurane via TREK-1 and TASK channel widening. The significance of volatile 
anesthetic action at these channels was supported by experiments by Heurteaux et al.21. 
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Heurteaux21 utilized mice with a “knock-out”, or genetically eliminated, TREK-1 
receptors. The mice demonstrated resistance to the volatile anesthetics chloroform, 
halothane, sevoflurane, isoflurane, and desflurane as evidenced by longer induction times 
and higher concentrations required to inhibit the righting reflex.  TREK-1 receptors are 
highly expressed in the hippocampal region of the brain, a region known to be associated 
with memory impairment after exposure to volatile anesthetics.41 
Discussion 
 The volume and significance of research provides many mechanisms that may be 
responsible for the effects of volatile anesthetics. The mechanisms described above are 
not a comprehensive list, but rather those with the most plausible physiology. Each of the 
different mechanisms of action listed above is individually or collectively relevant. The 
classic theories of anesthetic mechanism, including Meyer-Overton and Critical Volume 
Hypothesis, are also still relevant due to their practical application within clinical 
practice. With this improved understanding of current concepts in anesthesia mechanism, 
the relationships between volatile anesthetics and POCD have been elucidated.   
 The old and elderly, those >60 years and >75, are the greatest consumers of health 
care34. Individuals over age 65 account for 12% of the population, but undergo 40% of 
surgical procedures35. The old and the elderly, are more sensitive to anesthetics. The 
differences in pharmacokinetic and pharmacodynamic response are largely attributed to 
the aging of multiple organ systems. Physiologic changes result in a net reduction in 
anesthetic requirement, as well as increased duration of clinical effects.  Minimum 
alveolar concentration (MAC) is the concentration of an anesthetic where 50% of patients 
do not respond to a painful stimulus. This concentration is used as a means to compare 
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volatile anesthetic potency by age. With each increase in decade of life, the MAC of an 
anesthetic decreases 6.7%. The old and elderly are also more likely to express, through 
neurocognitive deterioration, neuronal damage from volatile anesthetics. Moller et al.28 
determined advanced age was associated with long term POCD. 
 In 2008, 16 researchers published a consensus statement regarding anesthesia and 
Alzheimer’s disease36. An eight-point summary included evidence from landmark and 
recent studies suggested an ominous relationship between anesthesia and Alzheimer’s 
disease. These points reviewed the links between volatile anesthetics and the 
neuropathologic sequelae. Finally, the group concluded with the importance of 
anesthetics outweighing the potential toxic effects and the critical need to continue 
studies into this relationship. 
 There is concern regarding inconsistencies in reliability and validity in this subject.  
The anesthetic models and MCI-AD studies have occurred mostly in vitro or in rat 
models at best. Studies in humans have been limited to protein biomarkers (cerebrospinal 
fluid), imaging, and neurocognitive testing37. The associated evidence of anesthesia 
neurological protein changes have occurred in tests tailored after similar AD studies, not 
those specifically developed for POCD. Also, there are questions regarding the relevance 
of neuronal damage and the degree of neurocognitive decline. 
 Understanding the mechanism of volatile anesthetics is not essential to the practice 
of anesthesia. This has been demonstrated over the past 100 years. Evolving 
understanding of mild cognitive impairment-Alzheimer’s disease and postoperative 
cognitive dysfunction makes anesthetic practice by ex juvantibus tenuous. Questions of 
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best practice, anesthetic selection, and even surgical modality all are increasingly relevant 
as POCD is better understood.   
  Still, there anesthetics induce apoptosis and/or β-amyloid aggregation, neuronal 
derangements. Anesthesia is definitely not benign. As more definitive models of 
anesthetic mechanism and MCI-AD pathways are studied, techniques to limit or avoid 
neurotoxic anesthetic exposure can be tested and evaluated in hopes of reducing negative 
anesthetic outcomes.  
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Figure 2.1.GABAA Receptor 
 
Source: http://neurocycletherapeutics.com/science/gabaa-receptor/ 
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CHAPTER THREE 
A Randomized Controlled Trial of Anesthesia Guided By BIS vs. Standard Care and 
Effects on Cognition 
Introduction 
 Postoperative cognitive dysfunction (POCD) is a subtle deterioration of cognitive 
function observed after exposure to inhalation anesthetics. In POCD, deficits in advanced 
cognitive functions and memory continue after appropriate anesthetic drug half-lives 
have expired, and may last from days to years.9 The incidence of POCD ranges from 10-
50% depending on definitions, study designs, sample sizes, and neurocognitive measured 
used.36 This cognitive decline is associated with increased one-year mortality, as well as 
morbidity and family/caregiver stress.37 Socially, these deficits also lead to earlier 
retirement, and greater reliance on social financial support systems.38 The cognitive 
domains thought to be most affected are attention, cognitive speed, executive function 
and memory.39 It is estimated that over 51 million individuals will undergo a procedure 
necessitating anesthesia annually, thus exposing a large segment of the population to 
potential POCD.1 
 Inhalation anesthetics have neuropathogenic effects similar to the changes seen in 
senile dementias, including Alzheimer’s disease. Based on these known properties of 
inhalation anesthetics, our overall hypothesis is that anesthetic techniques with greater 
cumulative deep hypnotic time result in a greater degree of POCD. It is possible to 
decrease cumulative deep hypnotic time by using derived electroencephalographic (EEG) 
monitoring to titrate volatile anesthetics. One of the major modalities for delivering EEG-
guided anesthesia is the Bispectral index™ system (BIS) (Covidien®). Using this system, 
cumulative deep hypnotic time can be reduced or eliminated without negatively affecting 
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patient physiologic stress or the surgical conditions. Derived EEG guided anesthesia has 
been demonstrated to improve recovery,40 reduce anesthetic consumption,41 and reduced 
delirium and confusion post-operatively.31  
 Despite the apparent benefits of BIS-guided anesthesia this technique is rarely used 
in practice. Reasons that this approach has not been adopted widely include 
misconceptions that BIS-guided anesthesia is used only to prevent surgical awareness of 
patients, beliefs that enhanced vigilance is required, lack of awareness by anesthesia 
providers about the effectiveness of such techniques, and the limited research testing this 
technique in randomized, controlled trials. 
 In order to provide rigorous data on the neurocognitive outcomes associated with 
BIS-guided anesthesia, we conducted a randomized controlled trial of BIS-guided 
anesthesia versus standard anesthesia using concentration-guided techniques. We used 
BIS in a tight reference range to avoid deep anesthesia (i.e., BIS <40) by maintaining a 
BIS range of 45-60. In addition, we used a state-of-the-art, highly sensitive 
neurocognitive testing system that is easy for patients of all ages to use in order to obtain 
valid and reproducible outcomes.  
 The specific aims of this study were: 
 Specific Aim 1.  To compare neurocognitive scores 3-5 days and 3-5 months post-
operatively between individuals undergoing anesthetic for surgery lasting greater than 2 
hours who were randomized to BIS guided anesthesia (group 1) or standard anesthesia 
care (group 2), 
 Specific Aim 2.  To compare neurocognitive scores among group 1 (BIS guided 
depth), group 2 (standard anesthesia care) and a third, non-randomized, normative group 
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(group 3) of individuals who did not have surgery or anesthesia, and who were age- and 
sex-matched to the surgical groups. 
Methods 
 Design.  This study was a prospective, randomized controlled trial. Parallel study 
groups underwent anesthesia for select surgeries and completed the Cambridge 
Neuropsychological Test Automated Battery-Mild Cognitive Impairment (CANTAB-
MCI®) at three intervals. The standard treatment group underwent anesthesia with 
inhalation anesthetics titrated around minimum alveolar concentration (MAC) values. 
Patients in the intervention group were titrated to BIS values 45-60, but not less than 0.5 
age adjusted MAC as measured by the Drager Apollo version 4.1. The CANTAB-MCI® 
was used to measure cognitive function and was done preoperatively, at 3-5 days 
postoperatively, and at 3-5 months post-operatively. The sample included 86 individuals, 
45 surgical patients randomized to intervention and 43 to standard treatment. An 
additional 37 age- and sex-matched individuals not undergoing surgery nor anesthesia 
were followed with neurocognitive testing at similar intervals to serve as a normative 
group.  
 Sample and Setting.  Patients aged 45-70 years undergoing general anesthesia for 
an elective surgical procedures scheduled to last approximately 2 hours at an academic 
medical center, who met selection criteria and agreed to participate were eligible for 
enrollment. After baseline data collection, patients were randomized to receive general 
anesthesia with either BIS guided titration or standard clinical practice. Computer 
randomization was utilized for randomization. The normative group was recruited from 
the community and a large group of them were the spouses of the participants. 
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 Inclusion criteria.  Inclusion criteria for patient participants was assessment as 
American Society of Anesthesiologist (ASA) class I-IV patients. These patients were 
selected from scheduled surgeries requiring general endotracheal anesthesia with 
neuromuscular paralytic. Individuals for the normative group were included if they were 
age 45-70, had not undergone surgery in the past 6 months, and had no surgery planned. 
Only participants (patients and non-patients) successfully completing the Motor 
Screening (MOT) test from the CANTAB-MCI® were invited to participate in the study. 
 Exclusion criteria.  We excluded individuals with significant cardiorespiratory or 
other end-organ disease (i.e., unstable angina, uncontrolled diabetes, severe peripheral 
vascular disease), inadequate English language skills, and/or substance abuse. We also 
excluded individuals with pre-existing neurological conditions (i.e., stroke, pre-existing 
cognitive dysfunction, and neuro-motor disabilities) and neurosurgical candidates. 
 Recruitment.  Patients were referred to the study by physicians and/or nurse 
practitioners working in the Preoperative Clinic and surgeons in the medical center. 
Study staff recruited individuals fitting inclusion/exclusion criteria after completing 
preoperative interview screening.  
 Intervention.  Anesthetic technique for both surgical groups included standard 
induction with available agents, neuromuscular paralysis guided by nerve stimulator, 
inhalation anesthetic, and intraoperative monitoring in accordance with the Department 
of Anesthesiology and ASA guidelines. Invasive monitoring, including arterial pressure, 
and central venous pressure was performed at the discretion of the anesthesia provider. 
 BIS monitors were applied to both groups. The anesthesia provider in the standard 
practice group was blinded to the BIS value via study blind. Titration and administration 
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were performed according to standard clinical practice judgment and optimal patient 
recovery in the standard treatment group. In the BIS group, the anesthesia provider 
titrated the volatile anesthetic to maintain a BIS index range 45-60, but not less than 0.5 
age adjusted MAC. 
 Select physicians and nurse anesthetists performed anesthesia, grouped by 
treatment and control. These individuals volunteered and underwent a well-defined 
training period and used well-defined anesthetic plans. Data were collected from the 
anesthetic record after each case. Intra-operatively, anesthesia clinicians aborted the study 
protocol as they deemed necessary for participant stability and safety. 
Measures 
 Demographic data.  Information including the following variables were collected 
by patient interview questionnaire: Age, sex, race/ethnicity, marital status and whether 
patient lives alone, education level, and annual income. 
 Clinical data.  American Society of Anesthesia physical status classification, 
previous anesthetics, current prescriptive medication regimen, physical exam, and 
comorbidities were obtained from the anesthetic record. All drugs utilized during the 
procedure were recorded on the anesthesia record and then transferred to a database for 
analysis.  In particular, inhalation anesthetic type as well as mean, median, and mode 
inspired and expired concentrations were recorded. Mean, median, and mode BIS scores 
were also collected from the anesthesia record. Total intraoperative anesthetic time was 
recorded. Perioperative narcotic exposure was discriminated by narcotic type and dose. 
 Neurocognitive testing.  Neurocognitive testing is an evaluation of a patient’s 
cognitive status by specific domain. Cognitive domains include attention/vigilance, 
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reasoning and problem solving, verbal learning and memory, visual learning and 
memory, language and verbal comprehension, working memory, speed of processing, 
general intellectual functioning, automaticity and procedural learning, psychomotricity, 
and perceptual processing. The CANTAB-MCI® system was used to measure cognitive 
function, and is a computerized, touch screen based group of 5 tests.  
 The CANTAB-MCI® battery includes the Motor Control Task (MOT), Delayed 
Matching to Sample (DMS), Rapid Visual Information Processing (RVP), Paired 
Associates Learning (PAL), and Reaction Time (RTI). Tests are scored by number of 
correct responses and/or time to complete task as appropriate. Test/re-test reliability of 
versions of CANTAB-MCI® test have been reviewed favorably in previous studies of 
postoperative cognitive dysfunction and validity of the method has been established.42 
 The MOT (2 minutes) is a simple introduction to the touch screen for 
the participant. This task also functions as a screening test for visual, movement and 
comprehension difficulties. Each participant successfully completed this task prior to 
enrollment in the study, and again successfully completed the task before each 
subsequent testing session. 
 The DMS (10 minutes) assesses cognition in the memory domain for non-
verbalizable patterns, testing both simultaneous and short term visual memory domains. 
These non-verbalizable patterns are shown, and after a brief delay, one of four patterns 
are matched to the original. This test assesses latency or the participant's speed of 
response/speed of processing domains. We used the outcome measure, ‘DMS percent 
correct’. This outcome measure reports the total number (as a percentage), of correct 
selections made on the participant’s first response (higher score is better). 
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 The RVP (7 minutes) tests sustained attention by assessing the participant’s ability 
to recall a sequence of digits when given different combinations of digits. The RVP is 
sensitive for the visual sustained attention domain. We used two outcome measures to 
reflect this domain, ‘RVP A’ ’ and ‘RVP median latency’. The RVP A’ (this denotes 
RVP A prime) measures the sensitivity to the target, regardless of response tendency 
(scored 0.00 to 1.0; bad to good), or how good the participant is at detecting target 
sequences. The RVP median latency is measured in milliseconds, and shorter is better. 
 The PAL (10 minutes) assesses the short term/visual memory domain. The PAL is 
useful for assessing individuals with questionable dementia, MCI, Alzheimer's disease, 
and age-related memory loss. Patients are asked to associate visual patterns that cannot be 
verbalized with spatial locations on the computer screen. We used two outcome measures 
to reflect this domain, ‘PAL total errors 6 shapes adjusted’ and ‘PAL total errors 
adjusted’. The ‘PAL total errors adjusted’ measures the total number of errors across all 
assessed problems and all stages with adjustment for each stage not attempted due to 
previous stage failures. The lower the score the better. The ‘PAL total errors 6 shapes 
adjusted’ is a measure in an advanced stage of the test and can discriminate subtle 
decrements in cognition in high functioning individuals. The lower the score the better. 
 The final domain test is the RTI (5 minutes). The RTI test is a speed of 
processing/latency domain task with a comparative history (the five choice task) and uses 
a procedure to separate response latency from movement time. This allows for control for 
participants with tremor. This test involves the use of a press pad controlled by the 
participant’s dominate index finger  
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 The ‘RTI mean simple reaction time’ measures the speed at which the participant 
releases the press pad button in response to a stimulus from a single location. This test is 
the mean of the measure reflecting cognitive recognition, lower scores reflecting better 
performance. ‘RTI median simple reaction time’ measures the same speed of press pad 
button response. The test reflects the median of the measure of cognitive recognition and 
is sensitive for slowing, with lower scores reflecting better performance. ‘RTI median 
simple movement time’ is the median time, measured in milliseconds, taken to touch the 
stimulus after the press pad has been released in response to a single stimuli. This is a 
measurement of the motor speed and is sensitive for slowing. The lower the score, the 
better. ‘RTI median five choice movement’ is the median of the measurement of speed 
with which the press pad button is released in response to a stimulus in any of five 
locations. Lower score is better. 
 Protocol.  The study proceeded after approval from the appropriate university 
Institutional Review Board, and after informed consent was received. Informed consent 
was obtained by Collaborative Institutional Training Initiative (CITI) trained study staff 
from all patients and non-surgical participants fitting inclusion criteria who agreed to 
participate. All research records were secured on computers with university encryption 
systems. After successful completion of the screening Motor Control Task (MOT), a full 
consent was completed when the patient agreed to participate. 
 The CANTAB-MCI® battery was administered upon attaining consent (baseline, 
test time 1). A version of the battery was administered on post-anesthetic day 3-5 (test 
time 2), in the patients’ hospital room, service’s clinic, or location convenient to the 
patient. Three to five days is an appropriate time period that would ensure drug half-lives 
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have expired. The battery was again re-administered at 3-5 months (test time 3) at a 
location convenient to the patient.  
 Data Analysis.  Data analysis included a descriptive summary, including means and 
standard deviations or frequency distributions, as appropriate. Comparisons of the groups 
at baseline was done using two-sample t-tests, chi-square tests of association or ANOVA.  
 To address each of the two Specific Aims, two-way mixed (i.e., one within subjects 
variable [time] and one between subjects variable [group]) repeated measures analysis of 
variance (ANOVA) was used. Each of the assumptions of repeated measures ANOVA 
(no significant outliers, the dependent variable is approximately normally distributed for 
each level of the independent variable, homogeneity of variances and covariances, and 
sphericity) were tested. The only violations across the various dependent measures were 
violations of the sphericity or homogeneity of variances assumptions. Both violations 
were managed using the appropriate p value correction. For example, when the sphericity 
assumption was violated, the p value was determined using the Greenhouse-Geiser 
correction. 
 When a significant group by time interaction was found, appropriate post-hoc pair-
wise and group-wise testing was done. Data analysis was conducted using SPSS, version 
22; an alpha level of < 0.05 used throughout. 
 Power considerations. With an alpha level of 0.05 and 34 individuals in each 
groups by the final assessment, the power of the repeated measures ANOVA F test to 
detect a significant main effect or interaction was at least 80%, assuming that the ratio of 
group means to the standard deviation of the observations within the populations was at 
least 0.25. Cohen43 considers this a medium effect size. This power analysis was 
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conservative because the methodology used to estimate the repeated measures models is 
robust with respect to missing data, as long as they are missing at random. The power 
estimates are expected to slightly underestimate the actual power, because we increased 
the sample size to allow for attrition with the goal of having at least 34 per group 
complete the study. Power analysis was conducted using nQuery Advisor, v. 6.02. 
Results 
 Flow of participants through the study.  We screened patients from October 2014 
through June 2015 with the last follow-up completed in September 2015. Of the 329 
patients eligible for enrollment, 143 did not meet eligibility criteria and 98 chose not to 
participate (Figure 1). Of the 88 patients scheduled for surgery who were enrolled, 45 
were randomized to the intervention limb of the protocol and 43 were randomized to the 
control protocol. Of the 45 patients allocated to the intervention limb, 2 (4.46%) were lost 
to follow-up prior to the anesthetic. In the control limb, 1 (2.3%) was lost prior to the 
anesthetic. Two patients from the intervention (4.46%) and control (4.6%) protocol limbs 
were lost to follow up prior to their cognitive testing session 2. Two (4.46%) more 
patients were lost to follow up prior to testing session 3 in the intervention limb of the 
protocol. There was no difference in rate of withdrawal from the two surgical groups 
(p=0.33). Patients who withdrew from the study were not significantly different than 
patients who remained in the study on any of the demographic or clinical characteristics 
measured at baseline including testing time 1 CANTAB-MCI® scores. 
 In addition we used purposive sampling to enroll an age matched healthy control 
sample. Seventy-two individuals were approached, with 10 not meeting inclusion criteria 
and 25 refusing participation. Thirty-seven individuals were enrolled with one lost to 
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follow up prior to testing time 2. This 36 participant group was age- and gender-matched 
to the surgical patient groups. 
 Sample Characteristics.  Of the 79 surgical patients available for analysis of 
cognitive outcomes at the last follow-up point (90% of the enrolled sample), the mean 
age was 59.1 ± 6.7 years of age, the majority were female (64.3%) and 
married/cohabitating 83 (72.2%). Seventy-seven percent had combined household 
incomes of less than $75,000 per year. The most common ASA classification was ASA II 
(46.8%), while 36.5% were classified as ASA III, and the remainder ASA I. The highest 
level of education attained was high school graduation/equivalent in 68.7%. 
Demographic and clinical characteristics of patients by total sample and group 
assignment are summarized in Table 1. There were no significant differences among the 
groups on any demographic or clinical characteristic.  
 Anesthetic Vapor.  Demonstrating the expected difference between the intervention 
group and the control, standard anesthesia techniques group, there were significant 
differences in mean concentration of inspired and expired anesthesia vapors between the 
groups summarized in Table 2. Specifically, the mean inspired and expired 
concentrations of anesthesia vapor were lower in the EEG guided group. Also 
demonstrating the expected difference between the groups, the BIS value was 
significantly higher in the treatment versus the control group (48.0 ± 4.6 vs 41.5 ± 6.9, p 
< 0.001). 
 With regard to safety of the intervention, there were no adverse effects seen in 
either group intra-operatively. Satisfactory anesthesia was provided for every patient in 
both groups. There were no instances of operative recall in either group at 3-5 days or 3-5 
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months post-operatively, even in the intervention group with age-adjusted MAC levels as 
low as 0.5. 
 Effect of EEG guided Therapy vs. Standard Anesthesia 
 Specific Aim 1. 
 The impact of the intervention on cognitive function was measured in four 
cognitive domains: memory (DMS percent correct), attention (RVP A’ and RVP median 
latency), visual memory (PAL total errors 6 shapes adjusted and PAL total errors 
adjusted), and speed of processing (RTI mean and median simple reaction times, RTI 
median simple movement time, and RTI median 5 choice movement).  
 Memory (non-verbalizable/patterns). Using repeated measures ANOVA, there was 
neither a group by time interaction or a time main effect for the outcome ‘DMS Percent 
Correct’ (Table 3, Figure 2).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
 Attention (visual sustained). Using repeated measures ANOVA, for both indicators 
of this domain ‘RVP A’ ’ (p=0.58) and ‘RVP median latency’ (p=0.55) there was no 
group by time interaction (Table 3, Figures 3 and 4). There was however, a main effect of 
time for both indictors (p=<0.001 and p=0.003 respectively). 
 Short term/visual memory domain. Using repeated measures ANOVA, we 
demonstrated significant group by time interactions in the multivariate overall test for 
both indicators, ‘PAL total errors 6 shapes adjusted’ (p=0.02) and ‘PAL total errors 
adjusted’ (p=0.02), of this domain (Table 3, Figures 5 and 6). 
 Post-hoc testing to determine at which time points the groups differed revealed that 
with regard to the ‘PAL total errors 6 shapes adjusted’ (Figure 5), the scores between the 
two groups were similar at baseline (p=0.75), but the trajectory across time diverged at 
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time two (p=0.019) in that the intervention group had better scores (lower) than the 
standard care/control group. At time three, there were again no differences between 
groups (p=0.32).  
 Post-hoc testing to determine where changes lie across time in each group, revealed 
that in the intervention group, there was a significant improvement in scores between 
time 1 to 2 (p=0.016), and time 1 to 3 (p=0.001), but not between time 2 and 3 (p=0.517). 
In the control/standard care group there was not a difference between time 1 and 2 
(p=0.196), but there was a significant improvement between time 2 to 3 (p=0.01) and 1 to 
3 (p=0.035). 
 In regard to ‘PAL total errors adjusted’ (Figure 6), the trajectories seen mirror those 
for ‘PAL total errors 6 shapes adjusted’. Post-hoc testing to determine at which time 
points the groups differed revealed that in regard to the ‘PAL total errors adjusted’ 
(Figure 2), the scores between the two groups were similar at baseline (p=0.76), and at 
time 2 (p=0.21). At time 3 the groups diverged (p=0.01) with the intervention group 
having better scores (lower) than the standard care/control group.  
 Post-hoc testing to determine where changes lie across time in each group revealed 
that in the intervention group, there was a significant improvement in scores between 
time 1 to 2 (p=0.01), and time 2 to 3 (p=0.07), but not between time 1 and 3 (p=0.38). In 
the control/standard care group there was a worsening of scores between time 1 and 2 
(p=0.02), and an improvement from time 2 to 3 (<0.001), and from time 1 to 3 (p=0.01). 
 Speed of processing/latency. The indicator ‘RTI mean simple reaction time’ 
demonstrated a significant group by time interaction (p=0.03). None of the other 
indicators were found to have significant group by time interactions (Table 3, Figure 7). 
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Regarding these three, ‘RTI median simple reaction time’ (p=0.07), ‘RTI median simple 
movement time’ (p=0.15), and ‘RTI median five choice movement time’ (p=0.06), there 
was no group by time interactions (Table 3, Figures 8, 9, and 10). There was a main 
effect of time for all (p=<0.001, p<0.001, p=0.001, and p=<0.001, respectively). 
Specifically, for both groups cognitive function worsened at time point two and returned 
to baseline by time three. 
 Post-hoc testing to determine at which time points the groups differed revealed that 
in regard to the ‘RTI mean simple reaction time’ (Figure 7), the scores between the two 
groups were similar at baseline (p=0.92), but the trajectory across time diverged at time 
two (p=0.04) in that the intervention group had better scores (lower) than the standard 
care/control group. At time three, there were again no differences between groups 
(p=0.4).  
 Post-hoc testing to determine where changes lie across time in each group, revealed 
that in the intervention group, there was a significant slowing of cognition in scores 
between time 1 to 2 (p=0.02), but not between time 2 and 3 (p=0.11), or time 1 to 3 
(p=0.56). In the control/standard care group there was a similar slowing between time 1 
and 2 (p=<0.001), and also from time 2 to 3 (p=<0.001), but there was no difference 
between time 1 to 3 (p=0.7). 
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Comparison of neurocognitive scores among group 1 (EEG guided), group 2 (standard 
anesthesia care) and group 3 (no anesthesia/surgery). 
Specific Aim 2. 
 Memory (non-verbalizable/patterns). Using repeated measures ANOVA, there was 
neither a group by time interaction nor a main effect for the outcome ‘DMS Percent 
Correct’ (P=0.3 and 0.5 respectively). (Table 4, Figure 11). 
 Attention (visual sustained).Using repeated measures ANOVA, for the indicator of 
this domain ‘RVP A’ ’ (p=0.03) (Table 4, Figure 12) there was a group by time 
interaction, but not for ‘RVP median latency’ (p=0.1) (Table 4, Figure 13). There was 
however, a main effect of time for both indictors (p=<0.001 and p=0.007 respectively). 
 Post-hoc testing to determine at which time points the groups differed revealed that 
in regard to the ‘RVP A’ ’ (Figure 12) there were group differences in the scores at 
baseline between intervention and normative (p=0.03), control/standard care and 
normative (p=0.004), but no difference between intervention and control (p=0.46), but at 
time three, there were no differences between groups (p=0.21). Time two group 
differences were similar in that intervention to normative groups (p=0.001) and 
control/standard care to normative (p=<0.001). Again, there was no significant 
differences between intervention to control/standard care at time two (0.4). Finally, there 
were no significant group differences at time three. Intervention to normative (p=0.2), 
control/standard care to normative (p=0.1), and intervention to control/standard care 
(p=1) all did not find significance. 
 Post-hoc testing to determine where changes lie across time within each group, 
revealed that in the intervention group, there was significance between time 2 to 3 
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(p=<0.001), but not time 1 to 2 (p=0.13), or between time 1 and 3 (p=0.07). In the 
control/standard care group there was not a difference between time 1 and 2 (p=0.15), but 
there was a significant improvement between time 2 to 3 (p=0.001) and 1 to 3 (p=0.007). 
In the normative group, there was not a significant difference over time (p=0.342) 
 Short term/visual memory domain. Using repeated measures ANOVA, we 
demonstrated significant group by time interactions in the multivariate overall test in both 
indicators ‘PAL total errors 6 shapes adjusted’ (p=<0.001) and ‘PAL total errors 
adjusted’ (p=0.005), of this domain (Table 4, Figure 14 and 15). There were also main 
effect of time for both ‘PAL total errors 6 shapes adjusted’ (p=<0.001) and ‘PAL total 
errors adjusted’ (p=0.005) (Table 4). 
 Post-hoc testing to determine at which time points the groups differed revealed that 
in regard to the ‘PAL total errors 6 shapes adjusted’ (Figure 14), there was not a 
significant difference amongst groups at base line. These values were intervention to 
normative (p=0.4), control/standard care to normative (p=0.6), and intervention to 
control/standard care (p=0.7). At time two the trajectory of the control/standard care 
group diverged from both the intervention group (p=0.01) and the normative group 
(p=<0.001). At time three there were no differences between groups, intervention to 
normative (p=0.3), control to normative (p=0.9), and intervention to control (p=0.4). 
 Post-hoc testing to determine where changes lie across time in each group, revealed 
that in the intervention group, between time 1 to 2 (p=0.016), and time 1 to 3 (p=0.001), 
but not between time 2 and 3 (p=0.5). In the control/standard care group there was not a 
difference between time 1 and 2 (p=0.2), but there was a significant improvement 
between time 2 to 3 (p=0.01) and 1 to 3 (p=0.04). The normative group demonstrated 
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significant differences between time 1 and 2 (p=<0.001) and time 1 and 2 (p=0.001), but 
not time 1 and 3 (p=0.2). 
 In regard to ‘PAL total errors adjusted’ (Figure 15), the trajectories seen mirror 
those seen for ‘PAL total errors 6 shapes adjusted’. Post-hoc testing to determine at 
which time points the groups differed revealed that in regard to the ‘PAL total errors 
adjusted’ there was no difference among the groups at time one. Intervention compared to 
control (p=0.7), intervention to normative (p=0.5) and control to normative (p=0.3) all 
were not significant. The scores at time two demonstrated difference between the 
intervention to control (p=0.004) and control to normative (p=<0.001), but not between 
the Intervention to normative (p=0.3). At time three the groups again were not significant 
with the Intervention group to control (p=0.2), the Intervention to normative (p=0.7) and 
control group to normative (p=0.4). 
 Post-hoc testing to determine where changes lie across time in each group, revealed 
that in the intervention group, there was a significant improvement in scores between 
time 1 to 2 (p=0.01), but not time 2 to 3 (p=0.07), or between time 1 and 3 (p=0.4). In the 
control/standard care group there was a worsening of scores between time 1 and 2 
(p=0.02), and an improvement from time 2 to 3 (<0.001), and from time 1 to 3 (p=0.01). 
 Speed of processing/latency.  Two indicators were found to have significant group 
by time interactions. ‘RTI median simple reaction time’ (p=0.005), and ‘RTI median five 
choice movement time’ (p=0.005) both had group by time interactions (Table 4, Figures 
16 and 17). Two indicators, ‘RTI mean simple reaction time’ (p=0.1) and ‘RTI median 
simple movement time’ (p=0.1), did not have a significant group by time interaction 
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(Table 4, Figures 18 and 19). There was a significant main effect of time for all of these 
outcome measures (Table 4). 
 Post-hoc testing to determine at which time points the groups differed revealed that 
in regard to the ‘RTI median simple reaction time’ (Figure 16), the scores between the 
three groups were similar at baseline in that Intervention to control (p=0.6), Intervention 
to normative (p=0.7) and control to normative (p=0.4). Time two trajectory of the control 
group diverged with Intervention to control (p=0.02) and the control to normative 
(p=<0.001). The Intervention group mirrored the normative scores (0.1). At time three, 
there were again no differences between groups. The Intervention to control (p=0.6), 
Intervention to normative (p=0.9), and control to normative (p=0.5) did not demonstrate 
significance. 
 Post-hoc testing to determine where changes lie across time in each group, revealed 
that in the intervention group, there was a significant slowing of cognition in scores 
between time 1 to 2 (p=<0.001), and between time 2 and 3 (p=<0.001), but not between 
time 1 to 3 (p=0.8). In the control/standard care group similarly slowing between time 1 
and 2 (p=<0.001), and also from time 2 to 3 (p=<0.001), but there was no difference 
between time 1 to 3 (p=0.7). The normative group performed similarly, with scores from 
time 1 to 2 (p=0.2) and 2 to 3 (p=0.05) significant. Scores at time 1 to 3 were not 
significant (p=0.8). 
 In regard to the outcome measure ‘RTI median five choice movement time’, post-
hoc testing to determine at which time points the groups differed revealed (Figure 17), 
the scores between the three groups were similar at baseline in that Intervention to control 
(p=0.3), Intervention to normative (p=0.1) and control to normative (p=0.6). Time two 
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trajectory of the control group diverged with control to normative (p=0.002). The 
Intervention to normative (0.2), and Intervention to control (p=0.9) were not significant. 
At time three, there were again no differences between groups. The Intervention to 
control (p=0.5), Intervention to normative (p=0.4), and control to normative (p=0.1) did 
not demonstrate significance. 
 Post-hoc testing to determine where changes lie across time in each group, revealed 
that in the intervention group, there was not a significant difference in scores between 
time 1 to 2 (p=0.5), nor between time 1 and 3 (p=0.07), but there was a significant 
difference between time 2 to 3 (p=0.001). In the control/standard care group significance 
between time 1 and 2 (p=0.004), and also from time 2 to 3 (p=<0.001), but there was no 
difference between time 1 to 3 (p=0.1). There was not a significant change in normative 
group with scores from time 1 to 2 (p=0.6) and 2 to 3 (p=0.8), and 1 to 3 (p=0.6). 
Discussion 
 Cognitive decline seen in the dementias is associated with increased mortality.44 
Similarly, POCD is associated with higher morbidity and mortality.4 It is not clear if 
cognitive decline directly causes this increased mortality or is a peripheral contributor. In 
concert with these data, our data suggests that early POCD, even when transient, may 
identify patients who are vulnerable to later morbidity and mortality. If future studies 
support this association then those individuals with early POCD could be targeted for 
intervention to reduce later morbidity and mortality. Interventions to reduce the impact of 
POCD should focus on support, and referral to multidisciplinary providers where defects 
are found. 
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 We examined the impact of BIS-guided anesthesia on cognitive outcomes using a 
state-of-the art neurocognitive testing computerized platform and unlike others, we tested 
specific cognitive domains. We demonstrated significantly lower volatile anesthesia 
exposure in the intervention (BIS-guided anesthesia) compared to the control group 
(p=<0.001). We demonstrated the safety of the intervention in that there were no adverse 
events associated with its use. We also demonstrated cognitive decline in the visual 
memory domain in the control versus BIS-guided anesthesia group in the 3 – 5 day post-
surgery period compared to baseline, but not at the 3-5 month period. This reflects that 
POCD occurs in specific domains but may be time limited, reflecting the findings of 
some previous studies.3,4  
 Reflecting the main effect of time seen in the regression analyses with both the two 
surgical groups alone, and the three group analyses, both surgical groups demonstrated 
postoperative depression in cognitive function in every outcome measure (with the 
exception of DMS), but in every instance, the standard care group’s was more 
pronounced. These findings indicate there is a higher cognitive obstacle in the memory 
domains encountered by patients exposed to a higher cumulative dose of volatile 
anesthetic. The outcome measures ‘PAL total errors adjusted’ and ‘PAL total errors 6 
shapes adjusted’ were both sensitive to the treatment technique. The PAL component of 
the CANTAB-MCI battery reflects the greatest impairment, and severity of dysfunction, 
in MCI and AD45. The finding of ‘PAL total errors adjusted’ is of greatest concern due to 
a close relationship with amnestic MCI (aMCI)46. Hippocampal atrophy and loss of 
function is a known pattern beginning in MCI and advancing in AD. The recall of objects 
in space is a process involving the hippocampus directly tested in the PAL.47 Junkkila 
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and colleagues found the ‘PAL total errors adjusted’ variable accounted for the largest 
difference between aMCI and mild AD.48 This outcome measure reflects a significant 
cognitive decline in the visual memory domain. The association of these findings and the 
known neuropathologic inflammatory sequel of these anesthetics suggest these volatile 
anesthetics are not benign. 
 The memory impairments noted in our study with the use of standard anesthesia not 
guided by EEG have the potential to adversely influence patient discharge. If patients 
have memory impairments, they will be unable to adequately process and remember 
important discharge instructions. Even when instructions are written, they are very 
commonly standard instructions that lack the specificity and detail needed for each 
individual patient. Patients and family members have substantial difficulty remembering 
instructions even under ideal situations,49 and our results suggest that most post-operative 
patients have enough POCD to impair their ability to retain the information needed for 
successful discharge and recovery. 
 Our findings differ from two of the most recent studies investigating use of derived 
EEG guidance as a means to reduce the incidence of POCD. A large German study led by 
Radtke failed to find significant difference POCD between derived EEG guidance and 
standard care at day 7 (p=0.372) nor day 90 (p=0.062).32 Our study differs in that we 
utilized volatile anesthetics exclusively for maintenance, rather than introducing macro-
molar anesthetics (propofol), which could be considered a confounder. Other 
differentiation between the studies was that we utilized the complete CANTAB-MCI 
battery and examined differences in specific domains that we explicated a priori. 
Previous investigators who used the CANTAB-MCI reported cognitive function as a 
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global phenomenon (despite the fact that the CANTAB-MCI has no such measures) 
failing to take advantage of the precision offered by assessing cognitive function in 
domains. The CANTAB-MCI battery was designed for sensitivity in MCI, which shares 
effected domains with POCD. Radtke and colleagues utilized three CANTAB pre-tests of 
pattern recognition memory (PRM), spatial recognition memory (SRM), and choice 
reaction time. The PRM and SRM are designed to help prepare for the more robust PAL 
test. The remainder of their battery consisted of tests administered orally (visual verbal 
learning test and Stroop color word test). While the number of patients in their study was 
respectable (n=1155), the differences in methodology could easily account for the 
different findings. 
 The CODA trial was the second of the derived EEG guidance studies that have 
similarities with this study.30 This study found higher POCD at 3 months (p=0.02) rather 
than one week (p=0.06), opposite to the findings of our study, and much of the previous 
literature. Although the findings are similar in that BIS-monitored care demonstrates less 
POCD, the dramatic difference in early versus late findings could be related to the 
neurocognitive battery utilized in the CODA trail. In addition, similar to the Radtke 
study, there were a significant number of patients (n=99, 11%) who received macro-
molar anesthetic maintenance (propofol) along with the majority volatile anesthetic 
group. 
 As mentioned, this is the first utilization of the complete CANTAB-MCI battery in 
the study of POCD. The CANTAB-MCI was developed and tested in populations with 
mild cognitive impairment. Our study demonstrates that the CANTAB-MCI is sensitive 
enough to detect cognitive changes in the surgical anesthetic population. The study has 
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demonstrated ease-of-use and no burden for users in the perioperative environment.  The 
BIS-monitor allowed for anesthetic titration to low levels without experiencing an 
episode of recall.   
Limitations 
 Although this study had the strength of being a randomized, controlled study, it has 
limitations. The primary limitation was the smaller sample size, which limited our ability 
to determine any heterogeneity of treatment effect because we could not perform 
subgroup analyses. 
Conclusion 
 This study is important because it provides important data on patient 
neurocognitive outcomes that will assist all anesthesia providers to make evidence-based 
decisions about the optimal anesthetic techniques to promote best patient outcomes. 
Careful titration, as guided by the BIS-monitor, by experienced anesthetic providers can 
lead to a measurable improvement in patient outcomes. Taken in concert with previous 
findings, our results suggest that BIS-guided anesthesia is safe, results in lower total 
overall volatile anesthetic exposure and fewer disturbances in cognitive function and thus 
should be considered by more providers as the standard of care. 
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Table 3.1. Comparison of baseline characteristics among the three study arms (N=115) 
Characteristics Total, 
N=115 
Anesthesia 
Intervention, 
n=39 
Anesthesia 
Control, 
n=40 
Healthy 
Control, 
n=36 
P 
 Mean ± SD or n (%)  
Sociodemographics      
Age, years 59.1 ± 6.7 59.6 ± 6.8 58.5 ± 6.4 59.1 ± 6.9 0.76 
Female Gender 74 (64.3) 24 (61.5) 26 (65) 24 (67.6) 0.893 
Caucasian 
African-American 
Other 
105 (91.3) 
    7  (6.1) 
   3  (2.6) 
35 (89.7) 
2 (5.1) 
2 (5.1) 
38 (95) 
2 (5) 
0  
32 (88.9) 
3 (8.3) 
1 (2.8) 
0.640 
  Education 
  High school or some 
college 
  College graduate and 
greater 
 
 
79 (68.7) 
 
36 (31.3) 
 
 
13 (33.3) 
 
26 (66.7) 
 
 
15 (37.5) 
 
25 (62.5) 
 
 
9 (25) 
 
27 (75) 
0.498 
Annual household 
income 
    <$25,000 
    $25,001-$75,000 
     >$75,001 
 
 
24 (20.9) 
53 (46) 
38 (33) 
 
 
8 (20.5) 
21 (53.8) 
10 (25.6) 
 
 
13 (32.5) 
14 (35) 
13 (32.5) 
 
 
3 (8.3) 
18 (50) 
15 (41.7) 
0.076 
Currently married 83 (72.2) 28 (71.8) 26 (65) 29 (80.6) 0.319 
Surgical 
Characteristics 
     
  Body Mass Index, 
kg/m2 
32 ± 8.1 31.4 ± 7.6 32.7 ± 8.6  0.489 
  Premedication 
    None 
    Midazolam 
    Opioid 
 
29 (36.7) 
13 (16.5) 
37 (46.9) 
 
12 (30.8) 
4 (10.3) 
23 (59) 
 
17 (42.5) 
9 (22.5) 
14 (35) 
 0.084 
  Anesthesia Time 3:30 ± 
0:58 
3:27 ± 0:57 3:32 ± 0:59  0.71 
  ASA physical Status 
    Physical status 2 
    Physical status 3 
 
  37 (46.8) 
  42 (36.5) 
 
19 (48.7) 
20 (51.3) 
 
 
18 (45) 
22 (55) 
 0.823 
  Baseline systolic 
blood  pressure 
134 ± 
15.8 
133 ± 17.1 136 ± 14.5  0.387 
 Surgical procedure     0.394 
Open Abdominal 20 (25.3) 9 (23.1) 11 (27.5)   
Laparoscopic/Other 13 (16.5) 9 (23.1) 4 (10)   
Posterior Lateral 
Interbody Fusion 
31 (39.2) 13 (33.3) 18 (45)   
Minimally Invasive 
Back 
15 (19.2) 8 (20.5) 7 (17.5)   
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Table 3.2: Mean concentration of inspired and expired vapor, % 
 Intervention 
 
Anesthesia-Control 
 
 
Anesthetic 
Vapor 
Mean ± SD 
inspired 
concentration 
 
 
Mean ± SD 
expired 
concentration 
 
 
Mean ± SD 
inspired 
concentration 
 
Mean ± SD 
expired 
concentration 
 
Sevofluranea 
 
1.78 ± 0.12 € 1.5 ± 0.17 ¥ 2.45 ± 0.35 € 2.01 ± 0.19 ¥  
Desfluraneb 
 
4.54 ± 1.13 € 3.83 ± 0.64 ¥ 6.13 ± 0.97 € 5.56 ± 1.93 ¥  
Isofluranec 1.46 ± 0.9 € 1.1 ± 0.81 ¥ 1.37 ± 0.35 € 0.9 ± 0.17 ¥  
      
€ = p value of 0.002 for the interaction of group by inspired vapor; in post-hoc testing 
using Bonferroni correction, a vs b p value is < 0.001; a vs c p value is 0.491; b vs c p 
value is < 0.001. 
¥ = p value of 0.006 for the interaction of group by expired vapor; in post-hoc testing 
using Bonferroni correction, a vs b p value is < 0.001; a vs c p value is 0.713; b vs c p 
value is < 0.001. 
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Table 3.3: Neurocognitive function between 2 groups across time. 
Neurocognitive 
test and domain 
 Treatment/BIS 
Mean ± SD 
Anesthesia-
Control 
Mean ± SD 
Overall p-value 
Time main 
effect 
Interaction 
Memory (non-verbalizable/patterns) 
DMS Percent 
Correct 
 
Baseline 85.6±10 81.7±11.5 0.17 
0.74 Time 2 83.1±12.6 78.3±16.7 
Time 3 82.7±12 80.3±13.1 
Memory (short term/visual) 
PAL Total Errors 
Adjusted 
Baseline 39.4±34.4 41.6±32.1 <0.001 
0.02¥ Time 2 34.7±29.6 57.4±43.7 
Time 3 25.7±21.8 33.2±30.5 
PAL Total Errors 
6 Shapes Adjusted 
Baseline 12±10.1 11.3±9.6  0.002 
0.02¥ Time 2 7.5±9.9 13.6±12.5 
Time 3 6.6±5.9 8.3±9.3 
Attention (visual sustained)  
RVP A prime Baseline 0.88±0.05 0.87±0.06 <0.001 
0.58 Time 2 0.87±0.06 0.85±0.07 
Time 3 0.89±0.05 0.89±0.06 
RVP Median 
Latency 
Baseline 444.1±114.6 451.8±150.1 0.003 
0.55 Time 2 498.3±179 518.8±218.3 
Time 3 457.4±150.8 439.5±137.7 
Processing speed/ latency 
RTI Mean Simple 
Reaction Time 
Baseline 347.4±103.7 349.6±92.7 <0.001 
0.03¥ Time 2 390±88.4 438.6±117.7 
Time 3 362±121.5 343.5±67.5 
RTI Median 
Simple Reaction 
Time 
Baseline 309.3±54.7 316.4±59.1 <0.001 
0.07 Time 2 355.7±61.6 394±84.4 
Time 3 312.6±56.1 319±51.4 
RTI Median 
Simple Movement 
Time  
Baseline 590.9±332.4 522.3±130.8 0.001 
0.15 Time 2 576.3±145.2 615.7±216.4 
Time 3 494.9±86.9 485.7±97.4 
RTI Median Five 
Choice Movement 
Baseline 545.4±202.9 507.6±118.4 <0.001 
0.06 Time 2 567.7±144.6 640.4±266.5 
Time 3 486.1±84.7 474.1±94 
Legend.  DMS=Delayed Matching to Sample;  PAL= Paired Associates Learning; 
RTI= Reaction Time;  RVP=Rapid Visual Information Processing;  ¥ = Treatment 
different from control (p<0.05). 
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Table 3.4: Neurocognitive function among 3 groups across time 
Neurocognitive 
test and 
domain 
Treatment/BIS 
Mean ± SD 
Anesthesia-
Control 
Mean ± SD 
Healthy 
Control 
Mean ± SD 
Overall p-
value 
Main 
effect 
Interaction 
Memory (non-verbalizable/patterns) 
DMS Percent 
Correct
Baseline 85.6±10 81.7±11.5 84.7±10.8 0.5 
0.3 Time 2 83.1±12.6 78.3±16.7 86.5±10.8 
Time 3 82.7±12 80.3±13.1 87.5±10 
Memory (short term/visual) 
PAL Total 
Errors 
Adjusted 
Baseline 39.4±34.4 41.6±32.1 34.1±30 <0.001 
<0.001£ Time 2 34.7±29.6 57.4±43.7 25.6±27.1 
Time 3 25.7±21.8 33.2±30.5 28±32.6 
PAL Total 
Errors 6 
Shapes 
Adjusted 
Baseline 12±10.1 11.3±9.6 10.1±9.2 <0.001 
0.001 Time 2 7.5±9.9 13.6±12.5 4.6±7.6 
Time 3 6.6±5.9 8.3±9.3 8.4±9.6 
Attention (visual sustained) 
RVP A prime Baseline 0.88±0.05 0.87±0.06 0.91±0.04 <0.001 
0.03€£ Time 2 0.87±0.06 0.85±0.07 0.91±0.04 
Time 3 0.89±0.05 0.89±0.06 0.91±0.06 
RVP Median 
Latency 
Baseline 444.1±114.6 451.8±150.1 412.9±84.7 0.007 
0.1 Time 2 498.3±179 518.8±218.3 406.8±69 
Time 3 457.4±150.8 439.5±137.7 405.1±70.8 
Processing speed/ latency 
RTI Mean 
Simple 
Reaction Time 
Baseline 347.4±103.7 347±92.5 327.9±71.3 <0.001 
0.1£ Time 2 390±88.4 435.9±118 369.3±118.8 
Time 3 362±121.5 343.1±68.3 332.1±56.2 
RTI Median 
Simple 
Reaction Time 
Baseline 309.3±54.7 316.6±59.8 304±60 <0.001 
0.005£ Time 2 355.7±61.6 391.5±84 331.1±56.2 
Time 3 312.6±56.1 319.3±51.8 310.3±44.6 
RTI Median 
Simple 
Movement 
Time 
Baseline 590.9±332.4 523.5±132.3 519±220.3 0.003 
0.1 Time 2 576.3±145.2 617.5±218.9 510.8±105.6 
Time 3 494.9±86.9 486.4±98.5 494.9±76.8 
RTI Median 
Five Choice 
Movement 
Baseline 546.8±205.4 508.3±120 488±180.7 <0.001 
0.005 Time 2 569.5±146.1 642.7±269.6 507.4±94.8 
Time 3 487.1±84.7 474±95.2 503.3±77.4 
Legend.  DMS=Delayed Matching to Sample;  PAL= Paired Associates Learning; 
RTI= Reaction Time;  RVP=Rapid Visual Information Processing;  ¥ = Treatment 
different from control (p<0.05); £ = Control different from normative (p<0.05); 
€=Treatment different from normative (p,0.05). 
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Figure 3.1:  CONSORT Diagram Patient Flow Through Study. 
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CHAPTER FOUR 
Predictors of cognitive dysfunction from a randomized controlled trial of EEG-guided 
anesthesia compared to standard care 
Introduction 
Anesthetics are a critical component of health care. It is estimated by the Centers 
for Disease Control and Prevention that over 51 million surgical procedures requiring 
anesthesia were performed in 2010.1 Anesthetics have become a common occurrence in 
society with risk perceived low by consumers. Improvements in safety have been 
attributed to technology and standardization of monitoring.50 Recent studies suggest that 
anesthesia-related mortality is 1.1 per million population per year.51 Still, the practice of 
anesthesia seeks to evolve and improve patient outcomes. 
Deficits in cognition have been reported for over fifty years.7 Post-operative 
cognitive dysfunction (POCD) has been identified as a risk for individuals undergoing 
surgery with volatile anesthetics.52  Post-operative cognitive dysfunction is defined as 
negative changes in cognitive function that continue after appropriate drug half-lives 
have expired. 53 Prediction of those patients likely to experience postoperative cognitive 
dysfunction (POCD) after surgery could provide clinicians with information on important 
risk factors for cognitive impairment. 
Several large randomized controlled trials have described risk factors for POCD. 
Most prominently, advanced age is described by many investigators as a principle 
preexisting risk factor.3,54 The seminal study of POCD is the International Study of Post-
Operative Cognitive Dysfunction (ISPOCD 1).3 Lower education attainment, anesthesia 
of extended duration, repeated operations, infections, and respiratory complications were 
risk factors for POCD. History of substance abuse is also a preoperative risk factor for 
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POCD.55 Predisposition to dementias (apoEε4 allele carriers) has been found to be a risk 
factor in some studies,56 but not in others.57,58  
We sought to evaluate a sample of patients who underwent surgery in a 
randomized controlled trial of EEG-augmented anesthesia to determine if there are 
baseline predictors of cognitive impairment at baseline and cognitive impairment after 
surgery. The patients in this study are evaluated by the cognitive battery, Cambridge 
Neuropsychological Test Automated Battery-Mild Cognitive Impairment® (CANTAB-
MCI). This study represents the first time the complete battery was utilized to evaluate 
patient outcomes after surgery with volatile anesthetics. Although many studies have 
evaluated risk factors for POCD, the neurocognitive batteries employed in these studies 
have required highly trained neuropsychologist.3,30,59 This study represents a practical 
application of a cost effective neurocognitive battery. 
Specific Aim 1: determine sociodemographic and clinical predictors of cognitive 
function in patients planned for surgery utilizing volatile anesthetics and in a normative 
group not undergoing surgery. 
Specific Aim 2: determine sociodemographic and clinical predictors of cognitive 
function in patients who have undergone surgery with a general anesthetic involving 
volatile anesthetics 
Methods 
Design. This is a secondary, planned data analysis of the prospective, randomized 
controlled trial, previously described in this dissertation.  Parallel study groups underwent 
anesthesia for select surgeries and completed the CANTAB-MCI pre-operatively and at 
3-4 days after surgery and 3-5 months after surgery. The standard treatment group were 
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anesthetized with volatile anesthetic and titrated with minimum alveolar concentration 
(MAC) values. The patients in the treatment group were titrated utilizing the Bispectral 
index™ system (BIS), an EEG-guided method of delivering anesthesia. 
Sample and Setting. The sample consisted of 88 individuals, 45 individuals 
randomized to the intervention and 43 individuals randomized to standard treatment.  
Additionally, 37 age-and sex-matched individuals not undergoing surgery nor anesthesia 
were followed with versions of the CANTAB-MCI at the same interval.  We included 
patient assessed as American Society of Anesthesiologist (ASA) class I-IV. These 
patients were undergoing scheduled surgeries requiring general endotracheal anesthesia 
with neuromuscular paralytic. Individuals for the normative group were included if they 
were age 45-70, had not undergone surgery in the past 6 months, and had no surgery 
planned. Only participants (patients and non-patients) who successfully completed the 
Motor Screening (MOT) test, which demonstrates muscular and cognitive ability to 
complete cognitive screening using the CANTAB-MCI, were invited to participate in the 
study. Patients were excluded who had significant cardiorespiratory or other end-organ 
disease, inadequate English language skills, and/or substance abuse. We also excluded 
patients with known neurological conditions (i.e., stroke, pre-existing cognitive 
dysfunction, and neuro-motor disabilities) and neurosurgical patients.  We received 
patient referrals from physicians and/or nurse practitioners working in the Preoperative 
Clinic and surgeons in the medical center. Intervention.  The intervention has been 
previously described, but in brief, anesthetic technique in both groups included standard 
induction with available agents, neuromuscular paralysis guided by nerve stimulator, 
inhalation anesthetic, and intraoperative monitoring.. 
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BIS monitors were applied to both groups. The anesthesia provider in the standard 
practice group was blinded to the BIS value. Titration and administration were performed 
according to standard clinical practice judgment in both groups, but in the BIS group, 
volatile anesthetic was titrated to maintain a BIS index range 45-60, but not less than 0.5 
age adjusted MAC. 
Measures 
Demographic and clinical data.  The following data were collected using a 
standard questionnaire: Age, sex, race/ethnicity, education level, and annual income.  The 
patients’ current prescriptive medication regimen, comorbidities were obtained from the 
preoperative anesthetic record. All drugs utilized during the procedure were recorded on 
the anesthesia record and then transferred to a database for analysis. 
Neurocognitive testing.  The CANTAB-MCI system was used to measure 
cognitive function in multiple domains, and is a computerized, touch screen based group 
of 5 tests. 
The CANTAB-MCI battery includes the Motor Control Task (MOT), Delayed 
Matching to Sample (DMS), Rapid Visual Information Processing (RVP), Paired 
Associates Learning (PAL), and Reaction Time (RTI). Reliability and validity of the 
method has been established.42The MOT (2 minutes) is a simple introduction to the touch 
screen for the participant. This task also functions as a screening test for visual, 
movement and comprehension difficulties. 
The DMS (DMS percent correct was used in this study) assesses cognition in the 
memory domain for non-verbalizable patterns, testing both simultaneous and short term 
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visual memory domains. DMS percent correct counts correct selections made on the 
participant’s first response and higher scores are better. 
The RVP (two outcome measures were used to reflect this domain, ‘RVP A’ ’ and 
‘RVP median latency’) tests cognition in the visual sustained attention domain by 
assessing the participant’s ability to recall a sequence of digits when given different 
combinations of digits. The RVP A’ measures how good the participant is at detecting 
target sequences and is scored (0.00 to 1.0; bad to good). The RVP median latency is 
measured in milliseconds, and shorter is better. 
The PAL (two measures were used to reflect this domain, ‘PAL total errors 6 
shapes adjusted’ and ‘PAL total errors adjusted’) assesses cognition in the short 
term/visual memory domain. For ‘PAL total errors adjusted’ lower scores are better, as 
they are for the ‘PAL total errors 6 shapes adjusted’. 
The RTI (RTI median simple reaction time was used to assess this domain) test is 
a speed of processing/latency domain task. ‘RTI median simple reaction time’ is sensitive 
for cognitive slowing, with lower scores reflecting better performance. 
Protocol.  The study proceeded after approval from the appropriate university 
Institutional Review Board, and after informed consent was received. After successful 
completion of the screening Motor Control Task (MOT), a full consent was completed 
when the patient agreed to participate. 
The CANTAB-MCI battery was administered in the patients’ hospital room, 
service’s clinic, or location convenient to the patient before surgery (time 1), at 3-5 days 
after surgery (time 2), and to ensure drug half-lives have expired. The battery was again 
re-administered at 3-5 months (time 3) at a location convenient to the patient. 
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Data Analysis 
We determined sociodemographic predictors (i.e., group, age, gender, education, 
income, and race) of cognitive function at baseline assessed in each of the four domains 
studied using separate nonlinear regression models and a continuous level, gamma with 
log link, response model. We initially attempted multiple linear regression modeling, but 
the major assumption of a linear relationship between the independent variables and the 
outcome variable was violated. Transformation of the outcome variable or appropriate 
independent variables did not resolve this violation, thus, nonlinear modeling with SPSS 
version 22 was done. 
Because only the two surgical groups had pre-surgical clinical information 
available, for time 2 (3-5 days after surgery) and time 3 (3-5 months after surgery), only 
surgical patients were included in the nonlinear regression models for time 2 and time 3.  
In order to optimize the model and avoid overfitting, we used only the sociodemographic 
variables that were consistently significant (i.e., age, income) from the baseline models, 
in the time 2 and time 3 models. Other predictor variables used in these time 2 and time 3 
models were group, ASA status, procedure, tobacco use, and psychotropic drug 
prescription.  We tested a small number of other reasonable candidate predictors (i.e., 
diagnosis of diabetes, length of anesthesia, on beta-blockers preoperatively, body mass 
index,  and baseline blood pressure) for inclusion in the models, and compared the 
Akaike Information Criterion (AIC) values to determine to best set of predictor variables 
that resulted in the lowest AICs across the models. 
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Results 
Flow of participants through the study.  We screened patients from October 2014 
through June 2015 with the last follow-up completed in September 2015. Of the 329 
patients screened for enrollment, 143 did not meet eligibility criteria and 98 chose not to 
participate (Figure 1). Of the 88 patients scheduled for surgery who were enrolled, 45 
were randomized to the intervention limb of the protocol and 43 were randomized to the 
control protocol. Of the 45 patients allocated to the intervention limb, 2 (4.46%) were lost 
to follow-up prior to the anesthetic. In the control limb, 1 (2.3%) was lost prior to the 
anesthetic. Two patients from the intervention (4.46%) and control (4.6%) protocol limbs 
were lost to follow up prior to their cognitive testing session 2. Two (4.46%) more 
patients were lost to follow up prior to testing session 3 in the intervention limb of the 
protocol. There was no difference in rate of withdrawal from the two surgical groups 
(p=0.33). Patients who withdrew from the study were not significantly different than 
patients who remained in the study on any of the demographic or clinical characteristics 
measured at baseline including testing time 1 CANTAB-MCI® scores. 
In addition we used purposive sampling to enroll an age- and gender-matched 
healthy control sample. Seventy-two individuals were approached, with 10 not meeting 
inclusion criteria and 25 refusing participation. Thirty-seven individuals were enrolled 
with one lost to follow up prior to testing time 2. 
Sample Characteristics.  Of the 125 surgical patients and normative participants 
available for analysis of cognitive outcomes at the last follow-up point (93% of the 
enrolled sample), the mean age was 58.9 ± 6.7 years of age, the majority were female 
(62.4%), and ethnicity coded as Caucasian 114 (91.2%). Sixty-eight percent had 
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combined household incomes of less than $75,000 per year. The highest level of 
education attained was at least some college in 69.5%. Demographic and clinical 
characteristics of patients by total sample and group assignment are summarized in Table 
1. There were no significant differences among the groups on any demographic or
clinical characteristic. 
Specific Aim 1 
We evaluated baseline sociodemographic (i.e., gender, age, education, income, 
and race) predictors of POCD in a population of patients from a randomized controlled 
trial utilizing BIS guidance versus standard care, and from a normative group who did not 
undergo surgery. Controlling for group assignment, we demonstrated that older age was 
predictive of poorer functional status at baseline in all of the dimensions measured except 
RTI (Table 2). Lower income (less than $25,000 per year compared to greater than 
$75,000) was predictive of worse cognitive function at baseline for the two cognitive 
domains reflected by the ‘DMS Percent Correct’ and ‘RVP A’’ . Education level lower 
than a completed college education was predictive of worse cognitive function in the 
domain represented by the PAL. Caucasian race was associated with poorer cognitive 
function compared to other races on the DMS. Gender was not associated with cognitive 
function in any dimension tested, and neither was group assignment. 
Specific Aim 2 
In addition to group, in the analyses for Specific Aim 2 (post-operative cognitive 
function), we used age and income as the sociodemographic predictors because (1) they 
were the most consistent predictors in the previous analysis, (2) education and income 
were highly correlated and thus, we thought it best to use only one of these predictors, 
72 
and (3) given our relatively smaller sample size we were limited in the number of 
variables that could be used as predictors. We used ASA status, surgical procedure 
planned, tobacco use, and prescription for psychotropic drugs as clinical predictors, after 
careful assessment of AIC values from different models. 
With regard to predictors of cognitive performance on CANTAB-MCI testing at 
time 2, (3-5 days after surgery) we found that, just as we found at baseline, older age and 
lower income were predictive of worse cognitive function (Table 3). Assignment to the 
EEG-guided anesthesia was associated with better cognitive function compared to the 
control group. Patients in the EEG-guided group were 60% less likely to demonstrate 
poor cognitive function than those in the control group. Other predictors of worse 
outcomes were planned neurological or spinal surgery and tobacco use, prescription of 
psychotropic drugs was not associated with cognitive outcomes. 
Table 4 summarizes characteristics predictive at CANTAB-MCI testing three (3-5 
months postoperatively). Assignment to the EEG guided group was associated with better 
outcomes in the PAL measure at 3-5 months postoperatively. Again, older age and lower 
incomes were predictive of worse cognitive function at 3-5 months after surgery. . Older 
age was predictive of worse cognitive function as reflected by three outcome measures 
‘DMS percent correct’,, ‘PAL Total Errors Adjusted’, and ‘RVP A’’ (p=0.001). The only 
other predictor of poor outcomes at time three was lower income. 
Discussion 
In this study, we confirmed the results of our randomized controlled trial in that 
patients in the EEG-guided anesthesia experienced better outcomes compared to those in  
the control group.  We demonstrated that a few variables that can be assessed prior to 
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surgery are important predictors of cognitive impairment before and after surgery. . 
Through each phase of assessment in this study, older age and lower income are 
consistent predictors of poorer cognitive function.  Our findings of advancing age and 
low education/income reflect the findings of previous studies.4 Older age is thought to be 
related to worse cognitive function due to decrements in cognitive function associated 
with physiologic changes associated with the development of chronic illnesses (e.g., 
small vascular infarcts or ischemia) and the accumulation of effects of lifestyle choices 
(e.g., smoking, hypertension, poor diet, sedentary lifestyle). Another possible contributor 
is a cohort effect associated with lower education levels in current elders. In our study, 
however, age was independently associated with cognition even when controlling for 
education level. 
An intriguing finding from our study was the effect of tobacco abuse on 
postoperative performance on all four cognitive outcome measures, where we 
demonstrated that tobacco abuse was associated with poorer cognitive outcomes at both 
post-operative testing times. Although hypoxemia has been postulated as a causative 
factor of POCD,60 the seminal randomized controlled trial of POCD (International Study 
of Post-Operative Cognitive Dysfunction: ISPOCD1) found that hypoxemia was not 
significant risk factors at any time.3 There were no significant episodes of hypoxemia 
noted among smokers or nonsmokers in our study, nor reported postoperatively. It is well 
known, however, that among nicotine-addicted smokers who attempt smoking cessation, 
cognition and attention are impaired.61 In addition, smoking is associated with intensive 
vasoconstriction, which may over time affect blood flow in the brain to produce subtle 
yet progressive changes in cognition. 
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 The concern of the effect of tobacco abuse is amplified in this study. Beyond the 
known cardiovascular and wound healing determents, this study finds that there are 
cognitive effects at the time interval of 3-5 days postoperatively. These individuals have a 
greater obstacle to overcome and have may have greater needs to be discharged. Their 
ability to be included in new fast-track regimens such as the Enhanced recovery after 
surgery (ERAS) protocol may be compromised.62 Nicotine effects continue to occur 3-4 
days after individuals last partake of tobacco products. While it is recommended that 
patients abstain from tobacco products six weeks prior to surgery, it is commonplace to 
find patients who have smoked heavily immediately prior to admission for surgery. 
 Previous studies have suggested that mood stabilizing medication have effects on 
cognitive performance.63,64 The use of psychotropic mood stabilizing medications did not 
prove to be significantly predictive of post-operative function in this study. This may be 
because other factors that were stronger risk factors for worse cognitive function 
overshadowed the potential impact of mood stabilizing medications. Moreover, we did 
not have dosage information or know the length of time patients were on these 
medications. 
Limitations 
 While the major strength is being a randomized controlled study, there are 
limitations to the study. The major limitation is a smaller sample size. This limits our 
ability to determine any heterogeneity of treatment effect because we could not perform 
subgroup analyses. 
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Conclusions 
Older age, lower income and tobacco abuse are predictive of worse cognitive 
outcomes, even in the company of specific procedural and clinical variables. All of these 
factors are easily identifiable to even the busiest clinicians. Use of these characteristics in 
the risk stratification of surgical candidates prior to surgery can assist healthcare 
providers to target at-risk patients for early intervention to prevent cognitive morbidity. 
76 
Table 4.1: Comparisons of baseline characteristics among the three study groups (N=115) 
Treatment/BIS 
n=45 
Anesthesia-
Control 
n=43 
Normative 
Group 
n=37 
P 
Age 60 ± 7 58 ± 6 59 ± 7 0.601 
Gender: male 19 (42%) 16 (37%) 12 (32%) 0.659 
Caucasian compared minority 41 (91%) 40 (93%) 33 (89%) 0.833 
Annual household income 
   <$25,000 
    $25,001-$50,000 
    $50,000-$75,000 
     >$75,001 
8   (20%) 
12 (29%) 
11 (27%) 
10 (24%) 
13 (32.5%) 
4   (10%) 
10 (25%) 
13 (32.5%) 
3   (8%) 
10 (28%) 
8   (22%) 
15 (42%) 
0.075 
Education 
   High school or Less 
 Some college or training  
   College graduate or more 
15 (36%) 
18 (43%) 
9   (21%) 
15 (37.5%) 
10 (25%) 
15 (37.5%) 
9  (25%) 
15 (42% 
12 (33%) 
0.279 
Legend:  BIS = Bispectral™ index system 
7
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Table 4.2: Baseline sociodemographic predictors of baseline cognitive function in four domains from the CANTAB-MCI.
DMS percent correct PAL Total Errors Adjusted RTI Median Simple Reaction Time RVP A’ 
Odds 
Ratio [95% CI] 
P value 
Odds 
Ratio [95% CI] 
P value 
Odds 
Ratio [95% CI] 
P value 
Odds 
Ratio [95% CI] 
P value 
Variable 
Group† 
  Treatment/BIS 
  Control/standard care 
1.025 [0.97-.08] 
0.987 [0.931-1.045] 
0.384 
0.642 
0.967 [0.684-1.362] 
1.153 [0.817-1.625] 
0.848 
0.413 
1.006 [0.93-1.087] 
1.035 [0.955-1.123] 
0.885 
0.396 
0.979 [0.954-1.004] 
0.997 [0.94-0.992] 
0.095 
0.01 
Gender: Male 0.973 [0.927-1.021] 0.26 1.109 [0.82-1.51] 0.505 1.014 [0.947-1.086] 0.686 1.003 [0.98-1.025] 0.8 
Age 0.994 [0.99-0.997] 0.001 1.035 [1.015-1.056] 0.001 1 [0.995-1.004] 0.873 0.997 [0.995-0.999] <0.001 
Education ‡ 
  High school or less 
  Some college or training 
0.983 [0.919-1.05] 
1.009[0.949-1.072] 
0.602 
0.776  
1.699 [1.132-2.552] 
1.579 [1.078-2.307] 
0.01 
0.018 
0.993 [0.904-1.09] 
1.061 [0.973-1.156] 
0.881 
0.178 
0.99 [0.962-1.02] 
0.995 [0.967-1.02] 
0.584 
0.703 
Income$ 
   <$25,000 
    $25,001-$50,000 
    $50,000-$75,000 
0.925 [0.857-0.997] 
0.987 [0.921-1.058] 
0.998 [0.937-1.062] 
0.04 
0.711 
0.937 
1.351 [0.851-2.154] 
1.312 [0.845-2.042] 
1.172 [0.791-1.746] 
0.2 
0.224 
0.427 
1.07 [0.964-1.192] 
1.005 [0.911-1.108] 
0.974 [0.892-1.063] 
0.198 
0.926 
0.547 
0.995 [0.922-0.988] 
0.982 [0.951-1.014] 
0.98 [0.952-1.008] 
0.008 
0.255 
0.154 
Caucasian £ 
(compared to all others)  
0.912 [0.838-0.99] 0.028 1.27 [0.73-2.101] 0.37 1.003 [0.891-1.126] 0.955 0.992 [0.956-1.03] 0.693 
Legend: BSI = Bispectral™ index system, DMS=Delayed Matching to Sample, PAL=Paired Associates Learning, RTI=Reaction Time, RVP A’=Rapid Visual Information Processing A 
prime 
Omnibus test: DMS p= 0.01; PAL p= 0.001; RTI p= 0.775; RVP p= <0.001.   
Variable compared to:  †= normative group; ‡=finished college or greater; $ = >$75,000; £= all others 
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Table 4.3: Baseline sociodemographic and procedural predictors of cognitive function within 3-5 days after surgery in four 
domains measured from the CANTAB-MCI battery. 
DMS percent correct PAL Total Errors Adjusted RTI Median Simple Reaction Time RVP A’ 
Odds 
Ratio [95% CI] 
P  Odds 
Ratio [95% CI] 
P  Odds 
Ratio [95% CI] 
P Odds 
Ratio [95% CI] 
P  
Variable 
Group† 
   BIS 1.058 [0.98-1.15]   0.18 0.595 [0.41-0.87]  0.008 0.91 [0.84-0.98] 0.018  1.01 [0.98-1.05]   0.38 
ASA score‡ 
   ASA 2 0.989 [0.91-1.1]    0.84 0.800 [0.54-1.19] <0.001 1.03 [0.95-1.12] 0.42 1.01 [0.98-1.04]   0.466 
Procedure‽ 
  Neuro/spin 
  Colorectal 
  General surgery 
0.876 [0.78-0.98] 
0.928 [0.8-1.07] 
0.923 [0.8-1.07] 
   0.026 
   0.32 
   0.29 
1.695 [0.99-2.89] 
1.642 [0.84-3.22] 
1.483 [0.75-2.93] 
  0.053 
  0.148 
  0.258 
1.18 [1.06-1.33] 
1.16 [1.01-1.34] 
1.24 [1.08-1.43] 
0.003 
0.036 
0.003 
 0.95 [0.91-0.993] 
 0.95 [0.894-0.998] 
0.95  [0.894-0.999] 
  0.024 
  0.043 
  0.044 
Age 0.992 [0.985-0.999]    0.02 1.06   [1.03-1.1] <0.001 1.01 [1.001-1.014] 0.027 0.99 [0.99-1]   0.107 
Tobacco use ₮ 
   No Tobacco use 1.202 [1.11-1.3] <0.001 0.618 [0.43-0.89]   0.003 0.89 [0.82-0.96] 0.004  1.03 [1.005-1.07]    0.023 
Income $ K 
    <$25-25  
    $25-$50 
    $50-$75 
0.983 [0.88-1.1] 
1.028 [0.91-1.16] 
0.986 [0.89-1.1] 
   0.78 
   0.66 
   0.799  
2.152 [1.25-3.69] 
2.086 [1.15-3.79] 
1.874 [1.15-3.06] 
 0.006 
 0.016 
 0.012 
0.993 [0.89-1.11] 
1.037 [0.92-1.17] 
0.967 [0.87-1.07] 
0.90 
0.54 
0.53 
0.96 [0.92-1.001] 
0.95 [0.91-0.996] 
0.96 [0.92-0.995] 
  0.053 
  0.033 
  0.027 
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Table 4.3 Continued 
DMS percent correct PAL Total Errors Adjusted RTI Median Simple Reaction Time RVP A’ 
Odds 
Ratio [95% CI] 
P  Odds 
Ratio [95% CI] 
P  Odds 
Ratio [95% CI] 
P Odds 
Ratio [95% CI] 
P  
Psychotropics £ 
    None 1.078 [0.99-1.17]    0.08 0.974 [0.67-1.43]  0.89 0.999 [0.92-1.09] 0.99 1.03 [1-1.07]   0.051 
Legend: CI=Confidence interval, DMS=Delayed Matching to Sample, PAL=Paired Associates Learning, RTI=Reaction Time, RVP A’=Rapid Visual Information Processing A 
prime.  
Omnibus test: DMS p=0.001; PAL p= <0.001; RTI p=0.007; RVP p=0.002.   
Variable compared to:  †= control/standard care group; ‡=ASA3&4; ‽ Laparoscopic;₮=smoker; $ = >$75,000; £= Psychotropic use 
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Table 4.4: Baseline sociodemographic and procedural predictors of cognitive function  within 3-5 months after surgery in 
four domains measured from the CANTAB-MCI battery. 
DMS percent correct PAL Total Errors Adjusted RTI Median Simple 
Reaction Time 
RVP A’ 
Odds 
Ratio [95% CI] 
P Odds 
Ratio [95% CI] 
P Odds 
Ratio [95% CI] 
P Odds 
Ratio [95% CI] 
P 
Variable 
Group∂ 
   BIS 0.032 [-0.028-0.99]    0.268 0.16 [-0.73—0.063]    0.02 0.037[-0.079-0.6] 0.833  0.0119 [-0.02-0.26]   0.795 
ASA score‡ 
   ASA 2 0.0334 [-0.067-0.06]    0.961 0.1703 [-0.33-0.34]   0.993 0.038 [-0.06-0.8] 0.816 0.001 [-0.005-0.001]   0.001 
Procedure‽ 
  Neuro/spine 
  Colorectal 
  General surgery 
0.0461 [-0.034-0.15] 
0.0594 [-0.065-0.17] 
0.0608 [-0.172-0.07] 
0.222 
0.385 
0.383 
0.241 [-0.642-0.3] 
0.3128 [-0.67-0.56] 
0.317 [-0.53-0.717] 
   0.477 
   0.859 
   0.761 
0.05 [-0.03-1.17] 
0.068 [-0.9-1.17] 
0.068 [-0.056 -0.2] 
0.187 
0.602 
0.256 
 0.017  [-0.06-0.005] 
 0.022 [-0.08-0.005] 
 0.022   [-0.09-0.01] 
=0.091 
  0.08 
  0.019 
Age 0.003 [-0.014--.003]   0.001 0.0135 [0.05-0.104] <0.001 0.003 [-0.004-
0.008] 
0.593  0.001 [-0.01-0.001]   0.001 
Tobacco use ₮ 
   No Tobacco use 0.0325 [-0.018-0.11]   0.164 0.1723 [-0.44-0.24]    0.569 0.037 [-0.14-0.007] 0.079 0.0119 [-0.01-0.042]    0.119 
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Table 4.4 Continued 
DMS percent correct PAL Total Errors Adjusted RTI Median Simple 
Reaction Time 
RVP A’ 
Odds 
Ratio [95% CI] 
P Odds 
Ratio [95% CI] 
P Odds 
Ratio [95% CI] 
P Odds 
Ratio [95% CI] 
P 
Income $ 
    <$25,000 
    $25,001-
$50,000 
    $50,000-
$75,000 
0.044 [-0.24--0.063] 
0.048 [-0.156-0.031] 
0.0425 [-0.103-0.63] 
   0.001 
   0.19 
   0.637 
0.2412 [0.002-0.95] 
0.2602 [0.29-1.31] 
0.2236 [-0.13-0.75] 
 0.049 
 0.002 
 0.168 
0.049 [-0.87-1.108] 
0.979 [-1.127-
0.084] 
1.043 [-0.059-
0.129] 
0.833 
0.691 
0.466 
0.016 [-0.095-0.03] 
0.018 [-0.09-0.019] 
0.016 [-0.046-0.02] 
 <0.001 
  0.002 
  0.33 
Legend: CI=Confidence interval, BIS = Bispectral index system. DMS=Delayed Matching to Sample, PAL=Paired Associates Learning, RTI=Reaction 
Time, RVP A’=Rapid Visual Information Processing A prime. 
Omnibus test: DMS p=0.004; PAL p= <0.001; RTI p=0.83 ; RVP p=0.001. 
Variable compared to: ∂=Diabetic ; ‡=ASA3; ‽ Laparoscopic;₮=smoker; $ = >$75,000. 
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CHAPTER FIVE 
Background and Purpose 
Over 51 million Americans underwent surgery in the last reported year.1 The 
fastest growing proportion of individuals are the elderly, and are the largest consumers of 
surgery.2 The development of postoperative cognitive dysfunction (POCD) after surgery 
is an important complication of surgery for many patients, likely more than appreciated 
by clinicians. Volatile anesthetics (e.g., isoflurane, sevoflurane, and desflurane) have 
been implicated in the development of POCD by triggeringneuroinflammation.14,20,21 This 
cognitive decline is associated with increased one-year mortality, as well as morbidity 
and family/caregiver stress.4  
The overall purpose of this dissertation was to determine whether an anesthetic 
technique, with less cumulative deep hypnotic time, results in fewer individuals with 
POCD. A large obstacle in the better understanding of POCD is that the exact mechanism 
of volatile anesthetics is still not known. To better understand this void, the manuscript in 
chapter 2 was developed and is a review of the current concepts of anesthesia 
mechanisms and the neuropathogenic effects on the aging brain was done. 
Based on findings from this manuscript, a randomized controlled trial of 
anesthesia guided by BIS vs. standard care and effects on cognition was undertaken, and 
was reported in Chapter 3. This randomized control trial of 115 individuals undergoing 
anesthesia (39 patients whose anesthesia delivery was guided by Bispectral Index® 
system [BIS-Covidien-Medtronic™] and 40 who received standard care) was conducted 
from August 2014-September of 2015. The group whose anesthesia was guided by the 
BIS system was predicted to have a lower overall cumulative dose of volatile anesthetic 
than their standard care counterparts.  After this trial, we conducted a secondary, 
 
 
83 
 
preplanned, data analysis (reported in Chapter 4) to determine risk factors for POCD 
among the surgery patients enrolled in the clinical trial. 
 EEG derived systems have been developed to measure depth of consciousness 
and enable the anesthesia provider to tailor anesthetics to the individual patient. Recent 
findings from studies utilizing the BIS system have demonstrated this titration is 
associated with positive outcomes in reduction of postoperative deficits.30,32 However, 
these studies have some limitations with regard to the measurement and reporting of 
cognitive function. This dissertation was innovative and resolved some gaps in the 
literature because we used the Cambridge Neuropsychological Test Automated Battery-
Mild Cognitive Impairment (CANTAB-MCI®), an instrument with known reliability and 
validity in a wide variety conditions, including the measured of pre- and post-operative 
cognitive function. This battery is delivered on a state of the art touch screen system and 
is highly regarded as one of the most rigorous methods of measuring cognitive function 
because it provides measurement of all relevant domains, and is objective and not open to 
investigator bias in interpretation. 
Summary of Findings 
Chapter Two was a focused review of the state of the science in the understanding 
of the mechanism of volatile anesthetic function. Beyond the Meyer-Overton theory, the 
protein theory of volatile anesthetic mechanism seems most plausible. The manipulation 
of gamma-aminobutyric acid (GABA) receptor proteins and the known inhibitory effect 
of chloride ion channels seem to be the machinery of anesthetic function. Still, bench 
scientists have produced additional examples of volatile anesthetic effect on proteins, 
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such as, N-methyl-D-aspartate receptors,65 and potassium channel subfamilies TREK1 
and TASK66.  
Studies to elucidate POCD have largely followed the affected cognitive domains. 
The association of POCD with mild cognitive impairment (MCI) has led researchers to 
compare the sequela of volatile anesthesia with  the neuropathogenesis of the 
dementias.67 Pathways including apoptosis,68 oligomerization,14 and caspase activation15 
have all been demonstrated with appropriate doses of volatile anesthetics, mimicking 
dementia neuropathogenesis. These close relationships between the dementias and the 
current concepts of anesthesia mechanism pose grave concern. Still, there is not a 
consensus on types of drugs, techniques, nor ways to monitor in mitigation of POCD.69 
Chapter Three is a report documenting a randomized controlled trial evaluating 
the effect of EEG guided anesthesia via the BIS monitor on cognitive function in surgical 
patients. In a sample of 86 individuals, 45 surgical patients randomized to the 
intervention of a balanced anesthetic technique with BIS guidance, and 43 to standard 
treatment. Cognitive performance was evaluated with the Cambridge Neuropsychological 
Test Automated Battery-Mild Cognitive Impairment (CANTAB-MCI®) at three intervals 
(preoperatively, 3-5 days post-operatively, and 3-5 months post-operatively).  
Our findings demonstrate statistically significant differences in two outcome 
measures of the Cambridge Cognition Paired Associates Learning (PAL) test. The PAL is 
a test of the short term/visual memory domain.   The outcome measures ‘PAL total errors 
adjusted’ (p=0.02) and ‘PAL total errors 6 shapes adjusted (p=0.02) were both 
significantly different in the time by group comparison at 3-5 days, but not at 3-5 months. 
A two-way mixed repeated measures ANOVA was utilized to address this specific aim. 
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The BIS group had significantly better cognitive outcomes at 3-5 days than did the 
treatment group who has a deficit in cognitive function in this domain after surgery. 
Cognitive function returned to baseline in both groups by the 3-5 month assessment.  An 
additional 37 age- and sex-matched individuals not undergoing surgery nor anesthesia 
were evaluated at the same intervals to represent a normative population. This study 
demonstrated that EEG guided anesthesia can reduce cumulative deep hypnotic time 
without negatively affecting patient physiologic stress or surgical conditions, while at the 
same time preventing cognitive dysfunction in some domains. 
 Chapter Four is a dissemination of a analysis of predictors of cognitive function 
from the randomized controlled trial, Chapter 3. Baseline predictors of poorer CANTAB-
MCI test performance to include older age and lower income regardless of group. At the 
second time period, the BIS guided treatment proved protective (p=0.008) for cognitive 
impairment, while older age and lower income remained predictive of worse cognitive 
function. At the long-term measurement period, older age, lower income, and assignment 
to the control group were associated with poorer outcomes. These findings are reflect 
larger studies, but were obtained with the cost-effective CANTAB-MCI system.4 
Impact of Dissertation on the State of the Science 
Health care, and its extraordinary cost, is a constant conundrum facing the United 
States and the world. Over the last 50 years, healthcare costs in the United States has 
escalated from 5 percent of GDP in 1960 to 17.4 percent in 2013.70 Many initiatives have 
been utilized to impact this escalation while seeking to preserve and improve patient 
outcomes. Recently, the Centers for Medicare & Medicaid Services (CMS) and 
America’s Health Insurance Plans (AHIP) released their first set of clinical quality 
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measures as part of their Core Quality Measures Collaborative also known as “pay for 
performance.” This initiative seeks to replace diagnosis-related groups (DRG) and 
International Statistical Classification of Diseases and Related Health Problems (ICD) as 
the central component for healthcare reimbursement. In the Core Quality Measures 
Collaborative, along with length of stay, factors such as controlling hypertension, timely 
screening, and appropriate medication regimens increase reimbursement.71 Over the last 
decade, a surgical practice model has evolved to address the same issues of balancing 
cost with quality. Enhanced Recovery After Surgery (ERAS®) is a set of multimodal 
care guidelines that include all facets of a surgical patients’ perioperative experience.62 
The ERAS® initiative drastically alters standard tenants of surgical care including 
reducing preoperative fasting, encouraging minimally invasive surgical approaches, and 
multimodal approaches to anesthesia care. The goal of ERAS® is prevention of physical 
and metabolic decline thereby allowing patients to recover more quickly. The ERAS® 
begins preoperatively with patient preparation and teaching, extends through the 
surgical/anesthetic phase, and includes critical components postoperatively through 
discharge/follow-up. Initial evaluations of the guidelines resulted in significantly 
improved morbidity and mortality (28.4% and 1.6% respectively) from previously 
reported studies (35% and 2%) (p=<0.0001 and p=0.156).72 In the past five years, the 
surgical approach has been extended successfully to other surgical practices.73-75 Patient 
participation, motivation, and communication are critical to the ERAS® approach. 
Patients unable to fully participate due to cognitive dysfunction postoperatively limit the 
ultimate effectiveness of the total approach. 
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This dissertation represents an important contribution to the literature as it is the 
first study to show that the CANTAB-MCI battery is effective in discriminating the fine 
difference in cognitive burden between two groups who underwent the stress of surgery. 
The CANTAB touch screen based system did not produce an undue burden on the 
patients, staff, nor require an unreasonable expenditure of time. The finding of significant 
differences in group performance on the Paired Associates Learning (PAL) test suggest 
that the BIS guided anesthesia technique may present some sparing effect on the integrity 
of the temporal lobe, especially the entorhinal cortex, as this area is critical for 
performance in the PAL.76 
Prior investigators have demonstrated that POCD is associated with higher 
morbidity and mortality.4 It is well established that cognitive decline, such as that seen in 
MCI, is associated with increased mortality.44 The causative relationship of cognitive 
decline to mortality is not clear. Bassuk and collegues44 clearly state that cognitive 
decline may, “interfere with the ability to recognize signs and symptoms of disease, to 
seek timely medical assistance, to adhere to a medication regimen, to prepare adequate 
meals, and to engage in other preventive health care behaviors.” While there is no clear 
relationship between POCD and MCI, the similarity of domains affected and 
neuropathology is telling. In concert with these data, our data suggests that early POCD, 
even when transient, may identify patients who are vulnerable to later morbidity and 
mortality. If future studies support this association then those individuals with early 
POCD could be targeted for intervention to reduce later morbidity and mortality.  Patients 
identified should have a multidisciplinary team who evaluates and forms a patient 
specific treatment plan targeted at optimal survivability. 
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Recommendations for Nursing Practice and Research 
The outcome of this dissertation suggests utilization of a BIS-guided, balanced 
anesthetic technique is effective in reducing effects of volatile anesthetics on 
postoperative cognition. Although many groups including the young and healthy may not 
present as at risk for POCD, the old, elderly, and frail should call for increased 
discrimination in the preoperative setting. Still, it is critical, that salient effects of 
anesthetics may still be occurring sub-clinically. Individuals with parents diagnosed with 
Alzheimer’s disease, known predisposition to dementias (apoEε4 allele carriers), and 
cerebral vascular disease should be counseled and anesthetic approach weighed against 
these risk. Utilization of cognitive batteries, such as, the CANTAB-MCI® can be utilized 
in these at risk populations when there is no other option for general anesthesia as a 
means to ascertain domains which may be affected. 
This study found susceptibility for deficits in visual memory/learning in 
individuals undergoing anesthesia with high cumulative hypnotic time. This was found at 
the 3-5 day time, but not in the late 3-5 month time. This finding is similar to that of 
larger studies of POCD.59 This presents a concern with patients undergoing healthcare 
teaching/discharge planning in this same time interval. Situations where patients receive 
complicated instructions or procedures they must understand to care for themselves at 
home may be lost due to cognitive deficits.   
The results of this and other studies suggest that special attention needs to be 
given to discharge education and that follow-up by phone or early return visits to the 
surgeon or primary care provider are warranted.  All discharge instruction should be 
explained to a family member or friend as well as to the patient. In addition, specific, 
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clear instructions should be written out.  It is common for written discharge instructions 
to be “generic” or not specifically tailored to the patient.  Given the potential for 
cognitive impairment after surgery, this practice should be avoided.  
Additional studies are planned to expand upon this study. For example, 
integrating a more complete understand of the neurocognitive effects of volatile 
anesthetics into the ERAS® approach and testing the outcomes of such integration should 
lead to interesting findings.  The old and the elderly, are at highest risk for poor outcomes 
in regard to POCD4 and surgical morbidity,77,78 therefore, it is prudent to approach these 
populations with great care.72 Further study, integrating the EEG guided anesthesia 
technique described in this dissertation, that is focused on improving outcomes in elders 
is warranted. 
Given the previous studies which have shown an association between POCD and 
higher morbidity and mortality in the long-term, it is interesting to speculate whether 
interventions could be specifically targeted to patients who experience POCD early after 
anesthesia. Our finding of early POCD in a specific domain suggests that even with 
apparent recovery of POCD, patients who experience early POCD may represent a 
vulnerable subset of patients who may experience worse outcomes in the long term. 
Further research is suggested to test this possibility and further refine interventions to 
improve outcomes after surgery. 
Conclusions 
 We were able to demonstrate a practical anesthesia technique can have an 
important impact on patient outcomes. While volatile anesthetics are a very important 
component of current anesthetic practice, evidence is substantial that they are not benign. 
 
 
90 
 
The Bispectral Index system is one of several EEG guidance systems that are prevalent 
throughout the United States. Their utilization in individuals identified to be at risk for 
cognitive decline after anesthesia (advanced age, low education/socioeconomic status, 
and tobacco abuse) is warranted, but all patients ultimately deserve the best care 
delivered in the optimal manner and thus, we recommend use of EEG guided anesthesia 
for all patients. The CANTAB-MCI system demonstrated rugged reliability, sensitivity, 
and ease of use. Utilization of this cognitive battery as a screening to, especially for at 
risk groups, could allow providers to follow these patients and personalize their care for 
their best outcomes. 
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